#  @willjohn1517 Elevator_Up ⬆️
Elevator_Up ⬆️ posts on X about $vktx, $nvo, $lly, $pfe the most. They currently have [-----] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.
### Engagements: [---] [#](/creator/twitter::37904332/interactions)

- [--] Week [---] +54%
- [--] Months [-----] -23%
- [--] Year [-----] -91%
### Mentions: [--] [#](/creator/twitter::37904332/posts_active)

### Followers: [-----] [#](/creator/twitter::37904332/followers)

- [--] Week [---] +0.17%
- [--] Month [---] -1.20%
- [--] Months [---] +1.90%
- [--] Year [---] +1%
### CreatorRank: [---------] [#](/creator/twitter::37904332/influencer_rank)

### Social Influence
**Social category influence**
[stocks](/list/stocks) [finance](/list/finance) [currencies](/list/currencies) [celebrities](/list/celebrities) [us election](/list/us-election) [countries](/list/countries) [cryptocurrencies](/list/cryptocurrencies) [travel destinations](/list/travel-destinations)
**Social topic influence**
[$vktx](/topic/$vktx) #44, [$nvo](/topic/$nvo), [$lly](/topic/$lly), [$pfe](/topic/$pfe), [ceo](/topic/ceo), [novo](/topic/novo), [nvo](/topic/nvo), [investment](/topic/investment), [glp1](/topic/glp1), [company](/topic/company)
**Top accounts mentioned or mentioned by**
[@gmeshortsqueeze](/creator/undefined) [@stocktwits](/creator/undefined) [@wallstreetbets](/creator/undefined) [@sbarron1950](/creator/undefined) [@elonmusk](/creator/undefined) [@benzystocks](/creator/undefined) [@bioinvestor24](/creator/undefined) [@mizuhoamericas](/creator/undefined) [@grassosteve](/creator/undefined) [@carterbworth](/creator/undefined) [@timseymour](/creator/undefined) [@timmypuffedit](/creator/undefined) [@semodough](/creator/undefined) [@wallstlobo](/creator/undefined) [@maziardoustdar](/creator/undefined) [@albertbourla](/creator/undefined) [@meadowcapital](/creator/undefined) [@biotech2k1](/creator/undefined) [@theguruyouknow](/creator/undefined) [@ryansttrader](/creator/undefined)
**Top assets mentioned**
[Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [Novo-Nordisk (NVO)](/topic/$nvo) [Eli Lilly and Company (LLY)](/topic/$lly) [Pfizer, Inc. (PFE)](/topic/$pfe) [GLP1 (GLP1)](/topic/glp1) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) [Nash (NEX)](/topic/nash) [Hims & Hers Health, Inc. (HIMS)](/topic/$hims) [AbbVie Inc (ABBV)](/topic/$abbv) [Structure Therapeutics Inc. (GPCR)](/topic/$gpcr) [Iovance Biotherapeutics, Inc. Common Stock (IOVA)](/topic/$iova) [AstraZeneca PLC (AZN)](/topic/$azn) [Biohaven Pharmaceutical Holding Company Ltd. (BHVN)](/topic/$bhvn) [Treasure (MAGIC)](/topic/treasure) [Evan (EVAN)](/topic/evan) [Viking Holdings Ltd (VIK)](/topic/viking)
### Top Social Posts
Top posts by engagements in the last [--] hours
"@Biotech2k1 $LLY is a bubble stock. Now thats an interesting interpretation. Whats its MC What Big Fish own huge stakes in the Company How long has it been an established Co. trading on the Stock exchange Cmon man - do better than that if you have a bear thesis- please ✔ $VKTX ✅"
[X Link](https://x.com/willjohn1517/status/1861021214082252864) 2024-11-25T12:16Z [---] followers, [---] engagements
"$VKTX $PFE @BenzyStocks There are dozens of clues about Pfizer interest in Viking last few weeks ( I and others summarized ) . It is a fact that doesnt need a rumor. The main issue is the value gap and how they can resolve that. Viking CEO will not sell less than $20 B ( watching this guy for years @BenzyStocks There are dozens of clues about Pfizer interest in Viking last few weeks ( I and others summarized ) . It is a fact that doesnt need a rumor. The main issue is the value gap and how they can resolve that. Viking CEO will not sell less than $20 B ( watching this guy for years"
[X Link](https://x.com/anyuser/status/1893400884744220913) 2025-02-22T20:42Z [---] followers, [---] engagements
"@TheGuruYouKnow $VKTX ✅ $VKTX Adding context to the type of sale: What is a 10b5-1 plan https://www.chase.com/personal/investments/learning-and-insights/article/stock-under-a-10b5-1-plan https://www.chase.com/personal/investments/learning-and-insights/article/stock-under-a-10b5-1-plan"
[X Link](https://x.com/willjohn1517/status/1850514893180469437) 2024-10-27T12:28Z [---] followers, [---] engagements
"$VKTX Posters #17 & #18 to be presented on 11/3 at 7:30p CST They are readouts for VK [----] (GLP-1/GIP) - - Studies. ✅ #OW2024"
[X Link](https://x.com/willjohn1517/status/1850819969254084912) 2024-10-28T08:40Z [---] followers, [---] engagements
"$VKTX ✅ $LLY $NOV Clear articulation of the key points regarding the Compounding Pharmacy issue - r/t the FDA Shortage List designation. Very Big money is involved. 💰 Lawsuit by Big Pharma in place. ✔ https://finance.yahoo.com/news/why-compounders-and-telehealth-providers-are-undeterred-by-the-potential-end-of-the-weight-loss-drug-shortage-154743126.html https://finance.yahoo.com/news/why-compounders-and-telehealth-providers-are-undeterred-by-the-potential-end-of-the-weight-loss-drug-shortage-154743126.html"
[X Link](https://x.com/willjohn1517/status/1850845224228020539) 2024-10-28T10:21Z [---] followers, [---] engagements
"$VKTX ✅ The concerns of quality have been long-standing Novo Nordisk recently provided a study looking at compounded versions of its drug which have caused [--] deaths and [---] hospitalizations or adverse reactions between October [----] and June 2024.) https://finance.yahoo.com/news/why-compounders-and-telehealth-providers-are-undeterred-by-the-potential-end-of-the-weight-loss-drug-shortage-154743126.html https://finance.yahoo.com/news/why-compounders-and-telehealth-providers-are-undeterred-by-the-potential-end-of-the-weight-loss-drug-shortage-154743126.html"
[X Link](https://x.com/willjohn1517/status/1850846707916902718) 2024-10-28T10:26Z [---] followers, [---] engagements
"@RyanSTTrader Its hard to fight against great molecules (VK2735 & VK2809) & a CEO who plays an adept game of Chess - for about [--] years. But we all have a certain destiny I guess $VKTX ✅ https://vikingtherapeutics.com/pipeline/overview/ https://vikingtherapeutics.com/pipeline/overview/"
[X Link](https://x.com/willjohn1517/status/1851926460283453512) 2024-10-31T09:57Z [---] followers, [---] engagements
"@bioinvestor24 Thanks for the assessment of the comparative study info - to date. $VKTX ✅"
[X Link](https://x.com/willjohn1517/status/1852146324314980838) 2024-11-01T00:31Z [---] followers, [---] engagements
"$VKTX ✅ / $IOVA ✅ $IOVA - When I decided to use my [--] years of pharma experience to identify biotech companies to invest last October of [----] I already had about [--] companies that I wanted to look into. The first one that I announced to you was $VKTX in December [----]. I got in at $11.65. I https://t.co/4QYl2W7rfc $IOVA - When I decided to use my [--] years of pharma experience to identify biotech companies to invest last October of [----] I already had about [--] companies that I wanted to look into. The first one that I announced to you was $VKTX in December [----]. I got in at $11.65. I"
[X Link](https://x.com/willjohn1517/status/1852760193563771364) 2024-11-02T17:10Z [---] followers, [---] engagements
"@bioinvestor24 @lfilipecastro Novo Nordisk recently provided a study looking at compounded versions of its drug which have caused [--] deaths and [---] hospitalizations or adverse reactions between October [----] and June 2024"
[X Link](https://x.com/willjohn1517/status/1852831701736575413) 2024-11-02T21:54Z [---] followers, [--] engagements
"$VKTX ✅ Embargo ✅ Abstracts are embargoed from media coverage until [--] PM Eastern Time on November [--] [----]. Site to Bookmark: https://obesityweek.org/attend/journalabstracts/ https://obesityweek.org/abstracts/embargo-policy/ https://obesityweek.org/attend/journalabstracts/ https://obesityweek.org/abstracts/embargo-policy/"
[X Link](https://x.com/willjohn1517/status/1852905997016223982) 2024-11-03T02:49Z [---] followers, 15.8K engagements
"$VKTX ✅- Analyst seems grounded in his comments regarding the Obesity Space - and said he would recommend buying into the SP drop of Viking today. Speculation on Pharma like Merck either partnering / or a takeout for 2x the current MC was suggested. 💰 https://x.com/nims213/status/1853573831681626578s=46&t=1QcLBVu6e2vMgGHKOtW4Jg CNBCFastMoney: Viking Therapeutics tumbles 13% 📉 @MizuhoAmericas strategist Jared Holz breaks down the data. #Biotech #Markets. @grassosteve @CarterBWorth @timseymour offer their insights $VKTX https://t.co/OTBloE3zyG"
[X Link](https://x.com/willjohn1517/status/1853583452039430410) 2024-11-04T23:41Z [---] followers, [---] engagements
"@CNBCFastMoney @MizuhoAmericas @grassosteve @CarterBWorth @timseymour $VKTX ✅ Data readout from #OW2024 vs other Pharma in the Obesity Space"
[X Link](https://x.com/willjohn1517/status/1853586310403178740) 2024-11-04T23:53Z [---] followers, [---] engagements
"$VKTX ✅ Too simplistic as a thesis for a 13% drop. That said: I do believe that Viking announcing a partnership deal with a big Pharma / or an outright takeout has increased odds due to VK2735 efficacy/ tolerability data from recent Study results for the oral/ & SQ"
[X Link](https://x.com/willjohn1517/status/1853717116274331957) 2024-11-05T08:32Z [---] followers, [---] engagements
"$VKTX ✅ #OW2024 - post conference data release &13% pullback of SP. More speculation on the why Bottom line of Yahoo Analysis- VK2735 validated efficacy/ tolerability from data and has value to a Big Pharma for possible M&A deal. ✔ 💰 https://finance.yahoo.com/video/viking-therapeutics-stock-falling-amid-210056194.htmlcontentType=VIDEO https://finance.yahoo.com/video/viking-therapeutics-stock-falling-amid-210056194.htmlcontentType=VIDEO"
[X Link](https://x.com/willjohn1517/status/1853727862483804207) 2024-11-05T09:15Z [---] followers, [---] engagements
"@sbarron1950 @GMEshortsqueeze @Stocktwits @wallstreetbets $VKTX ✅ 💰 Bookmarked this on 11/6/24 circa 2:15p. Current SP in graphic & MC is 7.21B. Ill get back to you when this goes over [--] or would you prefer over 100per share so you can apologize to Mr. Lian. 😄 This is a set it and forget it goldmine in the making. ✔"
[X Link](https://x.com/willjohn1517/status/1854242883252936756) 2024-11-06T19:22Z [---] followers, [---] engagements
"$VKTX ✅ VK2809 $VKTX next big catalyst is literally [--] weeks away have people forgetten they have MASH/NASH/Fibrosis drug VK2809 with a late breaker oral presentation at the Liver Meeting on Nov.19 $MDGL Redzdiffra only approved MASH drug on market big unmet need https://t.co/dACtmXCEds $VKTX next big catalyst is literally [--] weeks away have people forgetten they have MASH/NASH/Fibrosis drug VK2809 with a late breaker oral presentation at the Liver Meeting on Nov.19 $MDGL Redzdiffra only approved MASH drug on market big unmet need https://t.co/dACtmXCEds"
[X Link](https://x.com/willjohn1517/status/1854467254924058659) 2024-11-07T10:13Z [---] followers, [---] engagements
"@Davel3098534103 I dont do PTs Staying long for the big payout. These molecules given the projected TAM for GLP-1 Co-Agonists in this same class is a goldmine 💰 $VKTX ✅"
[X Link](https://x.com/willjohn1517/status/1854513246637597015) 2024-11-07T13:16Z [---] followers, [---] engagements
"$VKTX ✅ Wall Street dealmakers and corporate leaders expect the flood gates to open on merger and acquisition activity after President-elect Donald Trump takes office in January. https://www.cnbc.com/2024/11/07/wall-street-expects-trump-presidency-will-unlock-deal-making.html__source=iosappshare%7Ccom.google.chrome.ios.OpenExtension https://www.cnbc.com/2024/11/07/wall-street-expects-trump-presidency-will-unlock-deal-making.html__source=iosappshare%7Ccom.google.chrome.ios.OpenExtension"
[X Link](https://x.com/willjohn1517/status/1854593132740161751) 2024-11-07T18:33Z [---] followers, [---] engagements
"$VKTX #2 ✔ One top dealmaker expected an M & A uptick broadly but agreed that pharmaceuticals and the financial sector were particularly poised for a resurgence. https://www.cnbc.com/2024/11/07/wall-street-expects-trump-presidency-will-unlock-deal-making.html__source=iosappshare%7Ccom.google.chrome.ios.OpenExtension https://www.cnbc.com/2024/11/07/wall-street-expects-trump-presidency-will-unlock-deal-making.html__source=iosappshare%7Ccom.google.chrome.ios.OpenExtension"
[X Link](https://x.com/willjohn1517/status/1854596709847818310) 2024-11-07T18:48Z [---] followers, [---] engagements
"@NickMor19396581 @kiantrades Good question Ive downloaded the app to listen but its saying you will be notified when the call begins $VKTX ✅"
[X Link](https://x.com/willjohn1517/status/1854605026125083128) 2024-11-07T19:21Z [---] followers, [---] engagements
"For Sbarron: $VKTX ✅ Ive seen your history of posts r/t Viking and its quite apparent what your agenda is. So please quit the condescending - but rather help me calculate how much longs have made on this stock YTD carrying 5K shares Got a #"
[X Link](https://x.com/willjohn1517/status/1854616317070131550) 2024-11-07T20:06Z [---] followers, [---] engagements
"@vxxvix $VKTX Sparky whats the source of this speculation since its placed in quotes Thanks Do you have a link ✔"
[X Link](https://x.com/willjohn1517/status/1854625240485441539) 2024-11-07T20:41Z [---] followers, [----] engagements
"$VKTX ✅ $VKTX Thought provoking r/t the future of the Obesity Space- from 5/2024. ✔ The arrival of highly effective weight loss pharmacotherapies marked an inflection point for the obesity market. For the first time pharmacological interventions delivered meaningful I like this blog from @IQVIA_global (May 2024): When the dust settles: The future shape of the #obesity market. $NVO $LLY $ZEAL $GUBRA $VKTX $BIOA $AZN $RHHBY $PFE $AMGN $SRRK $BHVN $SKYE https://t.co/pmU7iO3N42 https://t.co/tweUQMESLC I like this blog from @IQVIA_global (May 2024): When the dust settles: The future shape of the"
[X Link](https://x.com/willjohn1517/status/1854855095256584694) 2024-11-08T11:54Z [---] followers, [---] engagements
"@_TGiR Agree with Bioinvester (above) MC currently is 7.64B. I would think the minimum the CEO would except is about 3x current- circa [--] to 23B. That would be a SP at BO of 3x or circa $205 per share. Obviously - speculation- but I think its more towards fair value"
[X Link](https://x.com/willjohn1517/status/1855061330245390500) 2024-11-09T01:34Z [---] followers, [---] engagements
"VKTX ✅ Yes Im sure that [--] out of [--] analysts that have a buy rating on Viking are all saying its based on a buyout scenario as well. Im calling out FUD - on this post below 👇 $VKTX for those blindly following a pharma guru peddling $VKTX buyout (who at most has predictions that are like coin toss having seen him for years) remember that his buys were much lower than what you would have now. so be prudent and dont blindly invest .jmo $VKTX for those blindly following a pharma guru peddling $VKTX buyout (who at most has predictions that are like coin toss having seen him for years) remember"
[X Link](https://x.com/willjohn1517/status/1855063774765470190) 2024-11-09T01:44Z [---] followers, [--] engagements
"@BIOTECHENIGMA VKTX ✅ Yes Im sure that [--] out of [--] analysts that have a buy rating on Viking are all saying its based on a buyout scenario as well. Is that your understanding Im calling out FUD - on this post above. ✔"
[X Link](https://x.com/willjohn1517/status/1855065225751400501) 2024-11-09T01:49Z [---] followers, [--] engagements
"$VKTX ✅ Yes for all the number crunchers its certainly about ROI. It would obviously be projections -but in healthcare its been an acceptable concept to secure bids on contracts called by various names- one of which is a predictive model. 💰 https://www.thestreet.com/lifestyle/health/new-healthcare-policy-changes-will-soon-affect-weight-loss-drugs https://www.thestreet.com/lifestyle/health/new-healthcare-policy-changes-will-soon-affect-weight-loss-drugs"
[X Link](https://x.com/willjohn1517/status/1855166884326383691) 2024-11-09T08:33Z [---] followers, [--] engagements
"United Healthcare whose parent Company is (UHG) uses it to win bids in a lucrative field termed Disease Management. As AI takes hold more and more in health care- it will be believable- this type of ROI (Return on Investment) for Government dollars. ✔ $VKTX ✅💰"
[X Link](https://x.com/willjohn1517/status/1855167458149101662) 2024-11-09T08:36Z [---] followers, [--] engagements
"$VKTX ✅ - Comparatives going forward will be both interesting & and a positive for attracting investment dollars. 💰 This week I have been digesting $NVO q3 [----] earnings report and I remain excited for the future ahead. My main interest being CagriSema and the potential it has. I want to see how it tops competitive drugs from $LLY and now $VKTX. Theres much upside in terms of valuation https://t.co/SueBSQ1Fxw This week I have been digesting $NVO q3 [----] earnings report and I remain excited for the future ahead. My main interest being CagriSema and the potential it has. I want to see how it"
[X Link](https://x.com/willjohn1517/status/1855170150460235951) 2024-11-09T08:46Z [---] followers, [---] engagements
"$VKTX ✅ Its likely we will hear increasingly r/t the GLP-1 discussions - - the manufacturing theme of peptides. ie: VK2735 It doesnt hurt to stay informed on some of the significant angles of this - - if interested. ✔ https://www.rootsanalysis.com/reports/peptide-therapeutics-manufacturing/305.html https://www.rootsanalysis.com/reports/peptide-therapeutics-manufacturing/305.html"
[X Link](https://x.com/willjohn1517/status/1855931645561328087) 2024-11-11T11:12Z [---] followers, [---] engagements
"$VKTX ✅ Question 3: What are the top peptide drugs by sales Answer: The top peptide therapeutics by sales are Ozempic (semaglutide) Rybelsus (semaglutide) Wegovy (semaglutide) Trulicity (dulaglutide) Mounjaro (tirzepatide) and Saxenda (liraglutide)"
[X Link](https://x.com/willjohn1517/status/1855935700786421860) 2024-11-11T11:28Z [---] followers, [---] engagements
"$VKTX ✅ Sbarron shortsighted as usual ✔ With that in mind Merck has ample cash on hand to forge deals w/ management expressing an appetite for assets across all stages of clinical development according to Leerinks M&A report. Deals is plural https://www.fiercepharma.com/pharma/bms-merck-amgen-and-more-must-pursue-ma-offset-looming-patent-lapses-leerink https://www.fiercepharma.com/pharma/bms-merck-amgen-and-more-must-pursue-ma-offset-looming-patent-lapses-leerink"
[X Link](https://x.com/willjohn1517/status/1857049888107721148) 2024-11-14T13:16Z [---] followers, [---] engagements
"@timmypuffedit @notmrmanziel $VKTX ✅ Better to do DD before spouting a vacant phrase or [--] One CEO- who has banked some 💰 from this 💎 stock and still owns over 2M shares. Hows that for skin in the game You also forgot to mention hes the founder going back to [----]. ✔ Facts are better than drivel. ✔"
[X Link](https://x.com/willjohn1517/status/1857119824070996188) 2024-11-14T17:54Z [---] followers, [---] engagements
"$VKTX Adjudicated death from CV causes or a worsening HF event occurred in [--] PTs (9.9%) in the tirzepatide grp & in [--] PTs (15.3%) in the placebo grp (hazard ratio 0.62; 95% confidence interval CI [----] to 0.95; P=0.026). Tirzepatide for HF w/ Preserved EF & Obesity"
[X Link](https://x.com/willjohn1517/status/1857829017132343510) 2024-11-16T16:52Z [---] followers, [---] engagements
"$VKTX ✅ $LLY $NVO $VKTX Treatment with tirzepatide led to a lower risk of a composite of death from cardiovascular causes or worsening heart failure than placebo and improved health status in patients with heart failure with preserved ejection fraction and obesity. $LLY $NVO $VKTX Treatment with tirzepatide led to a lower risk of a composite of death from cardiovascular causes or worsening heart failure than placebo and improved health status in patients with heart failure with preserved ejection fraction and obesity"
[X Link](https://x.com/willjohn1517/status/1858078115936788710) 2024-11-17T09:21Z [---] followers, [---] engagements
"$VKTX ✅ Making America Healthy Again One Quarter Pounder at a time 👀😂 Save one for me - Bobby 😋 👀👀 https://t.co/bxP7M0iRU5 👀👀 https://t.co/bxP7M0iRU5"
[X Link](https://x.com/willjohn1517/status/1858122918938456261) 2024-11-17T12:20Z [---] followers, [---] engagements
"$VKTX ✅ $VKTX approaching a price where their market cap reflects them only taking 1% of the $100B obesity market TAM and 0% of the NASH $30B TAM in [----] despite having the best drugs on the market.good times. $VKTX approaching a price where their market cap reflects them only taking 1% of the $100B obesity market TAM and 0% of the NASH $30B TAM in [----] despite having the best drugs on the market.good times"
[X Link](https://x.com/willjohn1517/status/1858441154959749195) 2024-11-18T09:24Z [---] followers, [---] engagements
"$VKTX ✅ @GMEshortsqueeze @Stocktwits @wallstreetbets - Sbarron is a bag of hot air $MDGL has a MC of 6.6B & its primary asset is MGL-3196 - is used for NASH. ✔ Viking will enter Phase [--] w/ VK2809. VKTX also has VK2735 which SQ - for Obesity Phase [--] in [----] ✔💰"
[X Link](https://x.com/willjohn1517/status/1858854569234547163) 2024-11-19T12:47Z [---] followers, [---] engagements
"$VKTX ✅ 💰 BTW: Somebody please let the dude know -who is usurping my time w/ thoughts about Viking only being worth circa $10 pps - that Ive given him a cheat sheet for the lack of DD below 👇 👇 Patience for the savvy investor in Viking will pay handsomely in the long run. $VKTX CEO "bulk of the value in our view is the injectable in the foreseeable future" as an induction for weight loss and transitioning to monthly subq or oral weekly. A very convenient regimen. $VKTX CEO "bulk of the value in our view is the injectable in the foreseeable future" as an induction for weight loss and"
[X Link](https://x.com/willjohn1517/status/1859031562391830834) 2024-11-20T00:30Z [---] followers, [----] engagements
"$VKTX ✅ $VKTX A lot of fake experts on X talk about "manufacturing challenges." But here's the official $VKTX line: 📍They reduced exposure to drug & patients MAINTAINED weight loss 📍That means LESS manufacturing will be needed 📍Speaking to multiple suppliers about "multi-ton" deals https://t.co/Ry6ptaVSRW $VKTX A lot of fake experts on X talk about "manufacturing challenges." But here's the official $VKTX line: 📍They reduced exposure to drug & patients MAINTAINED weight loss 📍That means LESS manufacturing will be needed 📍Speaking to multiple suppliers about "multi-ton" deals"
[X Link](https://x.com/willjohn1517/status/1859142854435545151) 2024-11-20T07:52Z [---] followers, [---] engagements
"@anni_sen Scott is the professional that should be leading the FDA again. He made the most sense of any authority during the COVID pandemic. I wish @realDonaldTrump & @elonmusk would pow wow with this guy $VKTX ✅"
[X Link](https://x.com/willjohn1517/status/1859293819637780845) 2024-11-20T17:52Z [---] followers, [---] engagements
"@Idvst8_Markets Thanks $VKTX ✅"
[X Link](https://x.com/willjohn1517/status/1859529923615965359) 2024-11-21T09:30Z [---] followers, [---] engagements
"@GMEshortsqueeze @wallstreetbets @Stocktwits $VKTX ✅ 💰 B. Riley analyst Mayank Mamtani initiated coverage of Viking Therapeutics (VKTX) with a Buy rating and $109 price target The firm has confidence in the long-term disruptive potential of the companys lead program VK2735"
[X Link](https://x.com/willjohn1517/status/1859913442834141409) 2024-11-22T10:54Z [---] followers, [---] engagements
"@elonmusk Thanks - Elon & Vivek ✔ $VKTX ✅ Here are some general thoughts related to this topic. ✔"
[X Link](https://x.com/willjohn1517/status/1859922222649143311) 2024-11-22T11:29Z [---] followers, [---] engagements
"$VKTX ✅ $VKTX Viking stands out as the only developer of a GLP-1/GIP dual agonist designed for both induction and maintenance therapy the analyst notes. Additionally B. Riley emphasizes that Viking has delivered a best-in-class oral dataset so far this year. $VKTX Viking stands out as the only developer of a GLP-1/GIP dual agonist designed for both induction and maintenance therapy the analyst notes. Additionally B. Riley emphasizes that Viking has delivered a best-in-class oral dataset so far this year"
[X Link](https://x.com/willjohn1517/status/1860012407185375627) 2024-11-22T17:28Z [---] followers, [----] engagements
"$VKTX ✅ Careful Adam - Viking has been green lately- now 50s and then 60s ✔ As Dylan sang: And don't speak too soon For the wheel's still in spin And there's no tellin' who That it's namin' For the loser now Will be later to win For the times they are a-changin' 🎶 $VKTX Now whats the catalyst to pull it out of a downward drift back to the $40s where it recently traded https://t.co/Pe5LXvUkIC $VKTX Now whats the catalyst to pull it out of a downward drift back to the $40s where it recently traded https://t.co/Pe5LXvUkIC"
[X Link](https://x.com/willjohn1517/status/1860295657350652335) 2024-11-23T12:13Z [---] followers, [---] engagements
"$VKTX ✅ [--] Monster Stocks in the Making: (Viking): Weight-loss management is the hottest therapeutic area in the pharmaceutical industry right now. Although the companies dominating the field are the usual suspects a notable mid-cap biotech is VKTX ✔ https://finance.yahoo.com/news/3-monster-stocks-making-113000110.html https://finance.yahoo.com/news/3-monster-stocks-making-113000110.html"
[X Link](https://x.com/willjohn1517/status/1860654158006673869) 2024-11-24T11:58Z [---] followers, [---] engagements
"$VKTX ✅ Cory Renauer The Motley Fool 11/25/24 Key Takeaways Billionaire Ken Griffins hedge fund Citadel has invested $93 million in Viking a clinical-stage drugmaker that could see its stock price rise 105% according to a Wall Street analyst. https://finance.yahoo.com/news/billionaire-ken-griffin-invested-93-092100240.html https://finance.yahoo.com/news/billionaire-ken-griffin-invested-93-092100240.html"
[X Link](https://x.com/willjohn1517/status/1861002495041921467) 2024-11-25T11:02Z [---] followers, [----] engagements
"$VKTX ✅ In the third quarter Griffin and Citadel more than tripled its stake in Viking Therapeutics. Griffin isnt the only one enthusiastic about this clinical-stage drugmaker. Wall Street analysts are sticking their necks out and predicting big gains around the corner.✔💰"
[X Link](https://x.com/willjohn1517/status/1861003870098375165) 2024-11-25T11:07Z [---] followers, [----] engagements
"@timmypuffedit Yeah please short Viking into EOY 2025- Ill thank you for your money 💰 $VKTX ✅"
[X Link](https://x.com/willjohn1517/status/1861051709587411351) 2024-11-25T14:17Z [---] followers, [---] engagements
"$VKTX ✅ $LLY Mounjaro TRx/NRx scripts for the week of 11/15/2024 were 436500/229400 (vs. 443100/233600 last week) per IQVIA data. Zepbound TRx/NRx scripts were 191000/137200 (vs. 190500/138300 last week). $NVO $VKTX $LLY Mounjaro TRx/NRx scripts for the week of 11/15/2024 were 436500/229400 (vs. 443100/233600 last week) per IQVIA data. Zepbound TRx/NRx scripts were 191000/137200 (vs. 190500/138300 last week). $NVO $VKTX"
[X Link](https://x.com/willjohn1517/status/1861054143898558661) 2024-11-25T14:27Z [---] followers, [---] engagements
"$VKTX ✅ @GMEshortsqueeze @Stocktwits @wallstreetbets SBarron1950. Blah Blah. ✔ As usual failed to mention the CEO holds over 2M shares & calculate that times the current SP ✔ BTW: it was green today in case you were wondering - 🤓"
[X Link](https://x.com/willjohn1517/status/1861521159222644768) 2024-11-26T21:23Z [---] followers, [---] engagements
"@Simsalabim2022 Ok - so this a did you know segment To stay with the juvenile tenor of your postLOL 😂 Vikes has 88% Institutional ownership vs 86% Tern - LOL 😂✔ $VKTX ✅ BTW any phase [--] molecule starting up soon for obesity"
[X Link](https://x.com/willjohn1517/status/1861529086096470289) 2024-11-26T21:54Z [---] followers, [---] engagements
"$VKTX $AMGN ✅ Amgen seems to be sinking in a lot of sweat and treasure into an Obesity candidate that has poor tolerability ✔ And to piecemeal the unveiling of a full data readout is a bush league strategy. In the end it will likely come back to bite them- w/ no ROI ✔ $AMGN $LLY $NVO $VKTX JP Morgan. Vomiting remained at 40% https://t.co/rzLuYXmEpo $AMGN $LLY $NVO $VKTX JP Morgan. Vomiting remained at 40% https://t.co/rzLuYXmEpo"
[X Link](https://x.com/willjohn1517/status/1861618378533658764) 2024-11-27T03:49Z [---] followers, [---] engagements
"$VKTX $LLY $NVO ✅ The proposed Medicare and Medicaid changes may be only the beginning analysts said. This marks a major evolution in the treatment of obesity as a disease said Evan Seigerman an analyst at BMO Capital Markets ✔ https://finance.yahoo.com/news/biden-proposes-medicare-medicaid-coverage-104108202.html https://finance.yahoo.com/news/biden-proposes-medicare-medicaid-coverage-104108202.html"
[X Link](https://x.com/willjohn1517/status/1861721634383581626) 2024-11-27T10:40Z [---] followers, [---] engagements
"$VKTX ✅ Evan Seigerman - We are starting to see the US healthcare system shift how it thinks about the treatment of metabolic disease moving from the long-held view that obesity was a lifestyle condition to the recognition that metabolic disease deserves real treatment. ✔"
[X Link](https://x.com/willjohn1517/status/1861722439908008358) 2024-11-27T10:43Z [---] followers, [---] engagements
"$VKTX $AMGN ✅ $VKTX Raymond James calling $AMGN out for the wild obfuscation of their data yesterday. When I was in Uni my professor would have chewed up me and spat me out for doing that. "What is this amateur hour No Y-Axis Every child knows to label their data" https://t.co/XSJ1jJDY11 $VKTX Raymond James calling $AMGN out for the wild obfuscation of their data yesterday. When I was in Uni my professor would have chewed up me and spat me out for doing that. "What is this amateur hour No Y-Axis Every child knows to label their data" https://t.co/XSJ1jJDY11"
[X Link](https://x.com/willjohn1517/status/1861885122271699064) 2024-11-27T21:29Z [---] followers, [---] engagements
"@gurgavin $VKTX ✅"
[X Link](https://x.com/willjohn1517/status/1862064260269973964) 2024-11-28T09:21Z [---] followers, [---] engagements
"$VKTX $NVO $LLY ✅ KEY FINDINGS Weight loss drugs are here to stay with 47% of respondents indicating that the impact of these treatments will be large and sustainable long term up from just 33% last year. https://www.reuters.com/business/healthcare-pharmaceuticals/healthcare-executives-expect-more-ipos-corporate-dealmaking-2025-2024-11-19/ https://www.reuters.com/business/healthcare-pharmaceuticals/healthcare-executives-expect-more-ipos-corporate-dealmaking-2025-2024-11-19/"
[X Link](https://x.com/willjohn1517/status/1862102292444377239) 2024-11-28T11:52Z [---] followers, [---] engagements
"$VKTX $NVO ✅ CONTEXT Earlier in November Novo Nordisk's Wegovy weight-loss drug sales beat its forecast in an obesity drug market that some analysts forecast could be worth about $150 billion by the early 2030s. At the moment demand outweighs supply"
[X Link](https://x.com/willjohn1517/status/1862102890786983957) 2024-11-28T11:55Z [---] followers, [---] engagements
"$VKTX ✅ Leerink;" $VKTX Lackluster MariTide Data Lift Competitive Overhang Boosting VK2735 Prospects; The results while nominally positive did not meet elevated investor expectations lifting a competitive overhang for $VKTX's (OP) VK2735 ('2735 GLP-1/GIP agonist) which we believe Leerink;" $VKTX Lackluster MariTide Data Lift Competitive Overhang Boosting VK2735 Prospects; The results while nominally positive did not meet elevated investor expectations lifting a competitive overhang for $VKTX's (OP) VK2735 ('2735 GLP-1/GIP agonist) which we believe"
[X Link](https://x.com/willjohn1517/status/1862424643170161040) 2024-11-29T09:13Z [---] followers, [---] engagements
"$VKTX ✅ Obesity ✔ Now desperate $VKTX longs getting some doctor to say that obesity isnt a choice. Its a result of mental weakness and poor decisions. There should be no sympathy for fat people. Now desperate $VKTX longs getting some doctor to say that obesity isnt a choice. Its a result of mental weakness and poor decisions. There should be no sympathy for fat people"
[X Link](https://x.com/anyuser/status/1863431552220180958) 2024-12-02T03:54Z [---] followers, [---] engagements
"$VKTX ✅ $LLY $NVO https://youtu.be/SmjVZYgyDx0si=Zak4F81S5qLpcmhA https://youtu.be/SmjVZYgyDx0si=Zak4F81S5qLpcmhA"
[X Link](https://x.com/willjohn1517/status/1863787491477602475) 2024-12-03T03:29Z [---] followers, [---] engagements
"$VKTX $LLY $NVO ✅ BMO highlighted a positive outlook for Eli Lilly product sales leading up to the holiday season. Analysts observed a notable uptick in total & new prescriptions for Lilly - diabetes obesity treatments Mounjaro & Zepbound which saw increases of 4.5% & 5.7%"
[X Link](https://x.com/willjohn1517/status/1863867992494289152) 2024-12-03T08:48Z [---] followers, [---] engagements
"$VKTX ✅ VA Under Secretary for Health Dr. Shereef Elnahal said roughly $2 billion of the $6.6 billion requested from Congress is needed for weight-loss drugs known as GLP-1 agonists & new medications for illnesses found in veterans such as MASH a fatty liver disease"
[X Link](https://x.com/willjohn1517/status/1863869624288166299) 2024-12-03T08:55Z [---] followers, [---] engagements
"$VKTX ✅ Current - Projected value to BP: [--]. TAM for Obesity drugs going to 130-150B annually by [----]. ✔ $VKTX Current Market Sentiment [--]. Positive results already be "priced in" [--]. Concerns about commercial viability or regulatory hurdles might limit the upside [--]. Negative results can lead to a major loss in value $VKTX Current Market Sentiment [--]. Positive results already be "priced in" [--]. Concerns about commercial viability or regulatory hurdles might limit the upside [--]. Negative results can lead to a major loss in value"
[X Link](https://x.com/willjohn1517/status/1864518416805081123) 2024-12-05T03:53Z [---] followers, [---] engagements
"$VKTX $LLY ✅ LONDON Dec [--] (Reuters) - Britains drugs cost-effectiveness watchdog NICE said on Thursday it will recommend the drug Mounjaro be made available to around [------] people in the country via the state health system over the next [--] years. https://www.reuters.com/business/healthcare-pharmaceuticals/britain-drug-cost-watchdog-says-it-will-recommend-lilly-obesity-drug-2024-12-05/ https://www.reuters.com/business/healthcare-pharmaceuticals/britain-drug-cost-watchdog-says-it-will-recommend-lilly-obesity-drug-2024-12-05/"
[X Link](https://x.com/willjohn1517/status/1864530830602780841) 2024-12-05T04:42Z [---] followers, [---] engagements
"@KingJohnOfMasha @UpdateNews724 Yo - he was a health insurance CEO - Its amazing how much folks are just like parrots 🦜 it the mind and speech anymore - ✔"
[X Link](https://x.com/willjohn1517/status/1864606118367949219) 2024-12-05T09:41Z [---] followers, [--] engagements
"$VKTX $LLY $NVO ✅ There are always exceptions to the rule as there are patients who lose weight with medication and then come off of it and keep the weight off but the overwhelming majority will need ongoing and chronic therapy they continued. https://www.freethink.com/biotech/obesity-rate-falling https://www.freethink.com/biotech/obesity-rate-falling"
[X Link](https://x.com/willjohn1517/status/1865419468652085502) 2024-12-07T15:33Z [---] followers, [---] engagements
"$VKTX $LLY ✅ Eli Lilly the company that makes the blockbuster weight loss treatment Zepbound will start studying its obesity products as treatments for alcohol and drug abuse making it the first major drugmaker to do so CEO David Ricks✔💰 https://www.statnews.com/2024/12/10/eli-lilly-zepbound-alcohol-drug-abuse-david-ricks/ https://www.statnews.com/2024/12/10/eli-lilly-zepbound-alcohol-drug-abuse-david-ricks/"
[X Link](https://x.com/willjohn1517/status/1866687681834725759) 2024-12-11T03:33Z [---] followers, [---] engagements
"$VKTX ✅ 1/ Over a century ago scientists uncovered a curious link between the gut & the pancreas. This sparked decades of research culminating in one of the greatest medical breakthroughs. This is the story of GLP-1 that I would like to share. 🧵 https://t.co/oW1XQSnmae 1/ Over a century ago scientists uncovered a curious link between the gut & the pancreas. This sparked decades of research culminating in one of the greatest medical breakthroughs. This is the story of GLP-1 that I would like to share. 🧵 https://t.co/oW1XQSnmae"
[X Link](https://x.com/willjohn1517/status/1866709591406547299) 2024-12-11T05:00Z [---] followers, [---] engagements
"$VKTX $PFE ✅ We strongly urge you to vote against the confirmation of his appointment as Secretary of the DHHS. Signed [--] Nobel Laureates in Medicine Chemistry Physics & Economics ✔ https://www.cnbc.com/amp/2024/12/11/healthy-returns-novo-nordisk-catalent-deal-closer-to-closing.html https://www.cnbc.com/amp/2024/12/11/healthy-returns-novo-nordisk-catalent-deal-closer-to-closing.html"
[X Link](https://x.com/willjohn1517/status/1867002081145655737) 2024-12-12T00:22Z [---] followers, [---] engagements
"$VKTX ✅ The post I'm quoting below by @BernardGoldste6 is outstanding 👏 has many good points on why a $VKTX has an increased probability for a near term buyout. I'm adding a few thoughts to what is quoted: There are many opportunities to maximize $VK2735 long term potential by The post I'm quoting below by @BernardGoldste6 is outstanding 👏 has many good points on why a $VKTX has an increased probability for a near term buyout. I'm adding a few thoughts to what is quoted: There are many opportunities to maximize $VK2735 long term potential by"
[X Link](https://x.com/willjohn1517/status/1867167124793221305) 2024-12-12T11:18Z [---] followers, [---] engagements
"$VKTX ✅ Is Viking Therapeutics ( $VKTX ) Preparing for a Buyout Several signals suggest that a major acquisition could be on the horizon for Viking. Heres a breakdown of whats happening and why it matters: Is Viking Therapeutics ( $VKTX ) Preparing for a Buyout Several signals suggest that a major acquisition could be on the horizon for Viking. Heres a breakdown of whats happening and why it matters:"
[X Link](https://x.com/willjohn1517/status/1867167954829471973) 2024-12-12T11:21Z [---] followers, [---] engagements
"$VKTX ✅ JUST NOW: Jim Cramer has exchange with RFK Jr. about Big Pharma vaccines CRAMER: "What do you think about GLP-1 drugs" RFK: "The best first thing is lifestyle: eating well making sure that you don't get obese. Those GLP drugs have a place." CRAMER: "A lot of people want to https://t.co/Vve0DEkAm7 JUST NOW: Jim Cramer has exchange with RFK Jr. about Big Pharma vaccines CRAMER: "What do you think about GLP-1 drugs" RFK: "The best first thing is lifestyle: eating well making sure that you don't get obese. Those GLP drugs have a place." CRAMER: "A lot of people want to"
[X Link](https://x.com/willjohn1517/status/1867407344163758118) 2024-12-13T03:13Z [---] followers, [---] engagements
"@Lance_Edelman @EricLDaugh Simplistic conclusion- talk to obesity experts who have worked with populations of those with BMI over [--] and come smell the coffee. Eating well and exercising have their place Its amazing how humans are so given to 🦜 parroting a belief system for their tribe. ✅"
[X Link](https://x.com/willjohn1517/status/1867408946819912085) 2024-12-13T03:19Z [---] followers, [----] engagements
"$VKTX ✅ Selling into the lap of Tutes 💰 Hmmm Institutional Shares (Long) [--------] - 89.11% (ex 13D/G) - change of 8.95MM shares 9.91% MRQ Institutional Value (Long) $ [-------] USD $VKTX Ive only heard of bigger pieces of shit than this dog $VKTX Ive only heard of bigger pieces of shit than this dog"
[X Link](https://x.com/willjohn1517/status/1867513753832468732) 2024-12-13T10:15Z [---] followers, [---] engagements
"$VKTX ✅ Somebody please let @SBarron1950 know ✔ - they are all buying the CEO propaganda hmmm - you probably know more than all the Tutes. 😂 *** $8.3M worth for this vacuum cleaner LOL 💰 https://www.marketbeat.com/instant-alerts/stifel-financial-corp-acquires-62956-shares-of-viking-therapeutics-inc-nasdaqvktx-2024-12-13/ https://www.marketbeat.com/instant-alerts/stifel-financial-corp-acquires-62956-shares-of-viking-therapeutics-inc-nasdaqvktx-2024-12-13/"
[X Link](https://x.com/willjohn1517/status/1867516763765711035) 2024-12-13T10:27Z [---] followers, [---] engagements
"$VKTX ✅ $NVO $VKTX - $BANB Bachem capacity to make #VK2735 for Viking has just increased. The reason is Bachem is down around 7% today on $NVO CagriSema news which means: ➡Clearly the market is assuming Bachem was going to be making the #Cagrilintide portion of #CagriSema for Novo. $VKTX - $BANB Bachem capacity to make #VK2735 for Viking has just increased. The reason is Bachem is down around 7% today on $NVO CagriSema news which means: ➡Clearly the market is assuming Bachem was going to be making the #Cagrilintide portion of #CagriSema for Novo"
[X Link](https://x.com/willjohn1517/status/1870423108118552958) 2024-12-21T10:56Z [---] followers, [---] engagements
"$VKTX ✅ $LLY $LLY FDA approves Zepbound (tirzepatide) as the 1st and only Rx medicine for mod-severe obstructive sleep apnea in adults with obesity Adults taking Zepbound had at least [--] fewer breathing interruptions/hr. Up to 50% had [--] symptoms after [--] year. https://t.co/4madjowHEW $LLY FDA approves Zepbound (tirzepatide) as the 1st and only Rx medicine for mod-severe obstructive sleep apnea in adults with obesity Adults taking Zepbound had at least [--] fewer breathing interruptions/hr. Up to 50% had [--] symptoms after [--] year. https://t.co/4madjowHEW"
[X Link](https://x.com/willjohn1517/status/1870424629883334895) 2024-12-21T11:02Z [---] followers, [---] engagements
"$VKTX $LLY ✅ Lilly obesity drug Mounjaro to be offered in Britains NHS after watchdog nod ✔ Mounjaro will be available through Britains state health system for some patients from March after the drugs cost-effectiveness watchdog NICE on Monday gave its blessing. ✔💰"
[X Link](https://x.com/willjohn1517/status/1871322001224466599) 2024-12-23T22:28Z [---] followers, [---] engagements
"$VKTX ✅ $NVO $LLY $VKTX This Musk experience is an anecdote and cant be generalized but from efficacy perspective Mounjaro clearly wins over ozempic. Data from UK (self pay ) clearly show people preference for GLP1 GIP dual agonist . CagriSema doesnt seem to be the answer to Mounjaro https://t.co/JVJtk17ICT $NVO $LLY $VKTX This Musk experience is an anecdote and cant be generalized but from efficacy perspective Mounjaro clearly wins over ozempic. Data from UK (self pay ) clearly show people preference for GLP1 GIP dual agonist . CagriSema doesnt seem to be the answer to Mounjaro"
[X Link](https://x.com/willjohn1517/status/1872236801378984260) 2024-12-26T11:03Z [---] followers, [---] engagements
"$VKTX ✅ $VKTX $NVO $AMGN If we dont hear Viking phase [--] start today Monday or Tuesday. It is almost certain BO or partnership of some sort . Sure the suppressed SP ( like all bios) argues against acquisition with very high premium and CEO last appearance at Stifel meeting didnt $VKTX $NVO $AMGN If we dont hear Viking phase [--] start today Monday or Tuesday. It is almost certain BO or partnership of some sort . Sure the suppressed SP ( like all bios) argues against acquisition with very high premium and CEO last appearance at Stifel meeting didnt"
[X Link](https://x.com/willjohn1517/status/1872768623271657543) 2024-12-27T22:16Z [---] followers, [---] engagements
"$VKTX ✅ Happy new year My selection for a few promising Bios for [----] based on wide addressable market and competitive pipeline. Not including ones that address rare diseases given the highly special aspect of that and the failure risk . Not financial advice 1- $VKTX best in class Happy new year My selection for a few promising Bios for [----] based on wide addressable market and competitive pipeline. Not including ones that address rare diseases given the highly special aspect of that and the failure risk . Not financial advice 1- $VKTX best in class"
[X Link](https://x.com/willjohn1517/status/1874934145270620314) 2025-01-02T21:41Z [---] followers, [----] engagements
"@ManOnThePen @elonmusk Buy $VKTX going into Phase [--] SQ to create competitive environment w/ Big Pharma like $LLY & $NVO - with a solid CDMO partnership- within [--] months- it could get to market ✅ Price will adjust. GLP/GIP Co-Agonist Agents have the best efficacy & tolerability to date ✔"
[X Link](https://x.com/willjohn1517/status/1875289447090286939) 2025-01-03T21:13Z [---] followers, [----] engagements
"$VKTX ✅ @sbarron1950 @GMEshortsqueeze @Stocktwits @wallstreetbets #JPM2025 I know SBarron will want to hear Dr. Lian present on 1/13 - addressing the value of the pipeline- I.e. VK2735 & VK2809 BTW: He maintains over 2.4M shares - did you happen to mention that 🤓💰"
[X Link](https://x.com/willjohn1517/status/1876431985125765591) 2025-01-07T00:53Z [---] followers, [---] engagements
"$VKTX ✅ CEO Brian Lian Ph.D. will deliver a corporate presentation ✔ 43rd Annual J.P. Morgan Healthcare Conference Dr. Lian will deliver a corporate presentation and participate in 1-on-1 meetings. Presentation Timing: 1:30 2:10 p.m. Pacific on Monday January [--] 2025"
[X Link](https://x.com/willjohn1517/status/1876432880877895915) 2025-01-07T00:57Z [---] followers, [---] engagements
"$VKTX $NVO $LLY $AMGN ✅ Oral - VK2735 * In process now - watch how quickly [--] weeks goes - & FDA green light on next stage ✔ Mid year readout likely ✔ FDA agreement to PH3 is very plausible if the expected data readout remains on target w/ efficacy & tolerability. ✔ $VKTX $AMGN $NVO $LLY $RHHBY Come on guys .this is not speculation . It is reality. BL just met with the FDA. There is no way on earth that he did not ask them about the oral program. He must have confirmed that its OK to proceed with oral phase [--] after this phase [--] or he $VKTX $AMGN $NVO $LLY $RHHBY Come on guys .this is not"
[X Link](https://x.com/willjohn1517/status/1877307621260095524) 2025-01-09T10:53Z [---] followers, [----] engagements
"$VKTX ✅ VK2735 $pfe $MRK $LLY $NVO $VKTX $Amgn Some CEOs continue to invoke next generation mechanisms in obesity Phase [--] trials clearly show by now that the best weight loss with tolerability balance comes from GLP1/GIP activation. CagriSema trial was phase [--] and clearly showed amylin is $pfe $MRK $LLY $NVO $VKTX $Amgn Some CEOs continue to invoke next generation mechanisms in obesity Phase [--] trials clearly show by now that the best weight loss with tolerability balance comes from GLP1/GIP activation. CagriSema trial was phase [--] and clearly showed amylin is"
[X Link](https://x.com/willjohn1517/status/1879744846434582689) 2025-01-16T04:17Z [---] followers, [---] engagements
"$VKTX ✅ $NVO $LLY TX plan & Insurance coverage for GLP-1 Discussion ✔ Desperate for help. "Patient is hoping in their next blood work that they will have type [--] diabetes so that they will qualify for GLP1 therapies". I 100% understand why someone would feel this way and that is a sad reflection upon medicine. Desperate for help. "Patient is hoping in their next blood work that they will have type [--] diabetes so that they will qualify for GLP1 therapies". I 100% understand why someone would feel this way and that is a sad reflection upon medicine"
[X Link](https://x.com/willjohn1517/status/1879753715470762303) 2025-01-16T04:53Z [---] followers, [---] engagements
"$VKTX One of the most promising contenders hoping to get in on the lucrative market is biotech Viking Therapeutics ✅ The company has an injectable weight-loss treatment starting late-stage clinical trials this year as well as an oral candidate in mid-stage trials. ✅ "
[X Link](https://x.com/willjohn1517/status/1882426825869238416) 2025-01-23T13:55Z [---] followers, [----] engagements
"$VKTX ✅ $VKTX $LLY $NVO $GPCR $AMGN $PFE With tirzapetide leadership position in obesity it is tempting to predict wt loss from the [--] remaining primary drugs in phase [--] or entering phase [--]. Namely; VK2735 and retatrutide I made my predictions of Maritide and CagriSema within narrow $VKTX $LLY $NVO $GPCR $AMGN $PFE With tirzapetide leadership position in obesity it is tempting to predict wt loss from the [--] remaining primary drugs in phase [--] or entering phase [--]. Namely; VK2735 and retatrutide I made my predictions of Maritide and CagriSema within narrow"
[X Link](https://x.com/willjohn1517/status/1882601790904193058) 2025-01-24T01:30Z [---] followers, [----] engagements
"$VKTX ✅ Buckle up - this is going to be very interesting regarding strategy and timing from the Brass at Viking ✔ Really like the move by CEO & BOD ✔ $VKTX buy back and what it could mean BTW I had a feeling the delayed 10K was going to be meaningful novice investors and bears didn't get it. A Pre-commercial biotech company buying back stock is very rare. Someone called $VKTX a scam yesterday if that's the case than $VKTX buy back and what it could mean BTW I had a feeling the delayed 10K was going to be meaningful novice investors and bears didn't get it. A Pre-commercial biotech company"
[X Link](https://x.com/anyuser/status/1894926988885782712) 2025-02-27T01:46Z [---] followers, [----] engagements
"$VKTX ✅ $VKTX VK2735 subQ once a month [--] injections while the current drugs require [--] injections. This adds significant Value More affordability More convenience More efficacy More tolerability This asset alone and its potential justifies a much greater valuation than current $VKTX VK2735 subQ once a month [--] injections while the current drugs require [--] injections. This adds significant Value More affordability More convenience More efficacy More tolerability This asset alone and its potential justifies a much greater valuation than current"
[X Link](https://x.com/willjohn1517/status/1854360730495054135) 2024-11-07T03:10Z [---] followers, [---] engagements
"$XBI is super frothy Fact: Up 10.2% YTD ✔ $VXTX ✅ 💰 Ken Griffin/ Citadel have a 93M stake saying otherwise. https://finance.yahoo.com/news/billionaire-ken-griffin-invested-93-092100240.html https://finance.yahoo.com/news/billionaire-ken-griffin-invested-93-092100240.html"
[X Link](https://x.com/willjohn1517/status/1861009484912505110) 2024-11-25T11:30Z [---] followers, [---] engagements
"$VKTX $NVO $HIMS Feb [--] (Reuters) - Hims & Hers said in a statement on Saturday that it will stop offering access to the compounded semaglutide pill after the U.S. Food and Drug Administration said it would take action against the telehealth provider for its $49 WT loss pill ✔"
[X Link](https://x.com/anyuser/status/2020231023657906334) 2026-02-07T20:19Z [---] followers, [---] engagements
"@semodough A. F. has been a basher for years regarding $VKTX Its curious whether or not financial incentives have been given to him or not I use to debate with him on the merits of Viking - but he insulates himself & then blocks any posters that have compelling points on the Company. ✔"
[X Link](https://x.com/willjohn1517/status/2022082737197449606) 2026-02-12T22:57Z [---] followers, [---] engagements
"@wallstlobo @semodough [--] phase [--] Trials will be moving along in [----] for the only GLP/GIP Co-Agonist in SQ & Oral form using the same molecule. 25M shorts w/ many being MMs are using it to scalp. Just wait till it gets close to FDA approval & commercialization (- $85 will look cheap) $VKTX"
[X Link](https://x.com/willjohn1517/status/2022583567339937939) 2026-02-14T08:07Z [---] followers, [---] engagements
"$VKTX ✅ Obesity ✔ Now desperate $VKTX longs getting some doctor to say that obesity isnt a choice. Its a result of mental weakness and poor decisions. There should be no sympathy for fat people. Now desperate $VKTX longs getting some doctor to say that obesity isnt a choice. Its a result of mental weakness and poor decisions. There should be no sympathy for fat people"
[X Link](https://x.com/anyuser/status/1863431552220180958) 2024-12-02T03:54Z [---] followers, [---] engagements
"$NVO $VKTX @maziardoustdar Quite succinct & compelling ✅ I am sorry $NVO @maziardoustdar . U r doing a good job but still not your scientists. U talk to Bloomberg ( below ) about big desire for M&A and describe that no one is better than Novo in valuing potential targets. But $PFE @AlbertBourla saved u from Metsera deal that I am sorry $NVO @maziardoustdar . U r doing a good job but still not your scientists. U talk to Bloomberg ( below ) about big desire for M&A and describe that no one is better than Novo in valuing potential targets. But $PFE @AlbertBourla saved u from Metsera deal that"
[X Link](https://x.com/anyuser/status/2021909461980602459) 2026-02-12T11:29Z [---] followers, [---] engagements
"I am sorry $NVO @maziardoustdar . U r doing a good job but still not your scientists. U talk to Bloomberg ( below ) about big desire for M&A and describe that no one is better than Novo in valuing potential targets. But $PFE @AlbertBourla saved u from Metsera deal that could have ended Novo position in top [--] obesity players by [----] Several other obesity hopefuls got their hands on GLP1 GIP dual agonists ( $RHHBY $REGN most recently $AZN ) $VKTX still has the best one by far the most advanced and moving oral to phase [--] . It will get it combined with oral amylin later this year. This could"
[X Link](https://x.com/anyuser/status/2021895420360765938) 2026-02-12T10:33Z [----] followers, [----] engagements
"$VKTX $NVO $HIMS Feb [--] (Reuters) - Hims & Hers said in a statement on Saturday that it will stop offering access to the compounded semaglutide pill after the U.S. Food and Drug Administration said it would take action against the telehealth provider for its $49 WT loss pill ✔"
[X Link](https://x.com/anyuser/status/2020231023657906334) 2026-02-07T20:19Z [---] followers, [---] engagements
"$VKTX ✅ $VKTX Stifel VK2735 boasts one of most flexible profiles in incretin landscape: most unique element of VK2735's development program is flexibility to transition patients from high doses to low maintenance doses. In Ph.2 VENTURE-Injectable 94% of all VK2735 (2.5 mg [--] mg [--] mg https://t.co/2bynNMMTt5 $VKTX Stifel VK2735 boasts one of most flexible profiles in incretin landscape: most unique element of VK2735's development program is flexibility to transition patients from high doses to low maintenance doses. In Ph.2 VENTURE-Injectable 94% of all VK2735 (2.5 mg [--] mg [--] mg"
[X Link](https://x.com/anyuser/status/1976630088734249100) 2025-10-10T12:45Z [---] followers, [---] engagements
"$VKTX Stifel VK2735 boasts one of most flexible profiles in incretin landscape: most unique element of VK2735's development program is flexibility to transition patients from high doses to low maintenance doses. In Ph.2 VENTURE-Injectable 94% of all VK2735 (2.5 mg [--] mg [--] mg and [--] mg) patients in the PK subset (N=63) maintained weight loss and 83% maintained weight loss out to [--] weeks post-treatment. In VENTURE-Oral an exploratory step-down maintenance cohort (rapidly up-titrated up to [--] mg over [--] weeks and dropped to [--] mg for the remaining [--] weeks) further extended weight loss"
[X Link](https://x.com/anyuser/status/1976601256232657039) 2025-10-10T10:50Z 42.5K followers, 25.6K engagements
"$VKTX ✅ $VKTX- Near term catalysts: Should start Ph2 Maintenance study in Obesity for #VK2735 this month that includes monthly subq and low dose oral options. (this one could happen any day now.) Should have IND and ph1 study in Amylin/Dacra Compound by EOY Vanquish PH3 subq https://t.co/6mSKykUz3p $VKTX- Near term catalysts: Should start Ph2 Maintenance study in Obesity for #VK2735 this month that includes monthly subq and low dose oral options. (this one could happen any day now.) Should have IND and ph1 study in Amylin/Dacra Compound by EOY Vanquish PH3 subq https://t.co/6mSKykUz3p"
[X Link](https://x.com/anyuser/status/1976629935742869640) 2025-10-10T12:44Z [---] followers, [---] engagements
"$VKTX- Near term catalysts: Should start Ph2 Maintenance study in Obesity for #VK2735 this month that includes monthly subq and low dose oral options. (this one could happen any day now.) Should have IND and ph1 study in Amylin/Dacra Compound by EOY Vanquish PH3 subq study initiated Jun 25th. Enrollment going well and next up is announcement of completion full enrollment. Other events that could drive the stock higher: - Renewed interest in MASH drugs due to MDGL success (and FDA relaxing Biopsy reqs for ph3) could lead to partnership of #VK2809 - Interest rates continue to decline and lead"
[X Link](https://x.com/anyuser/status/1976609314992189600) 2025-10-10T11:22Z [----] followers, 34.4K engagements
"$VKTX ✔ 💊 Stanley Druckenmiller just bought into Viking Therapeutics $VKTX. The stock is down 35% YTD. Why would a billionaire hedge fund legend double down here [--] $VKTX is chasing the $120 billion obesity drug market [--] Its pipeline shows early promise vs. Eli Lilly & Novo Nordisk 💊 Stanley Druckenmiller just bought into Viking Therapeutics $VKTX. The stock is down 35% YTD. Why would a billionaire hedge fund legend double down here [--] $VKTX is chasing the $120 billion obesity drug market [--] Its pipeline shows early promise vs. Eli Lilly & Novo Nordisk"
[X Link](https://x.com/anyuser/status/1960726360688599483) 2025-08-27T15:29Z [---] followers, [---] engagements
"💊 Stanley Druckenmiller just bought into Viking Therapeutics $VKTX. The stock is down 35% YTD. Why would a billionaire hedge fund legend double down here [--] $VKTX is chasing the $120 billion obesity drug market [--] Its pipeline shows early promise vs. Eli Lilly & Novo Nordisk $LLY $NVO [--] Druckenmiller already owns $LLY $VKTX could be his hedge or his multibagger bet This is asymmetric investing 101: small downside massive upside if even one drug hits. Is $VKTX the next big biotech breakout or another what could have been I break it down in my full analysis (free for followers). Follow"
[X Link](https://x.com/anyuser/status/1960718995461443746) 2025-08-27T15:00Z [----] followers, [----] engagements
"$VKTX ✔ $VKTX 30mg VK2735 was as tolerable as PLACEBO and after [--] weeks SAEs dropped dramatically. Guess what VKTX does in ph2b or ph3 They put patients on 30mg or less for a month and then titrate up as eventual terminal WL is IDENTICAL just takes about a month longer https://t.co/rAfpq9h1V7 $VKTX 30mg VK2735 was as tolerable as PLACEBO and after [--] weeks SAEs dropped dramatically. Guess what VKTX does in ph2b or ph3 They put patients on 30mg or less for a month and then titrate up as eventual terminal WL is IDENTICAL just takes about a month longer https://t.co/rAfpq9h1V7"
[X Link](https://x.com/anyuser/status/1960724182301335777) 2025-08-27T15:20Z [---] followers, [---] engagements
"$VKTX 30mg VK2735 was as tolerable as PLACEBO and after [--] weeks SAEs dropped dramatically. Guess what VKTX does in ph2b or ph3 They put patients on 30mg or less for a month and then titrate up as eventual terminal WL is IDENTICAL just takes about a month longer"
[X Link](https://x.com/anyuser/status/1960114372866687287) 2025-08-25T22:57Z [---] followers, [----] engagements
"$VKTX ✔ $vktx $lly Cross-trial comparisons with orforglipron show how competitive VK2735 results are at the [--] mg (maintenance dose) and [--] mg levels. VK2735 reached in [--] weeks what orfo required [--] weeks to achieve in P2 (with a faster titration) and even [--] weeks in P3 (with https://t.co/5ASnhWoH8D $vktx $lly Cross-trial comparisons with orforglipron show how competitive VK2735 results are at the [--] mg (maintenance dose) and [--] mg levels. VK2735 reached in [--] weeks what orfo required [--] weeks to achieve in P2 (with a faster titration) and even [--] weeks in P3 (with https://t.co/5ASnhWoH8D"
[X Link](https://x.com/anyuser/status/1960090188841099552) 2025-08-25T21:21Z [---] followers, [---] engagements
"$vktx $lly Cross-trial comparisons with orforglipron show how competitive VK2735 results are at the [--] mg (maintenance dose) and [--] mg levels. VK2735 reached in [--] weeks what orfo required [--] weeks to achieve in P2 (with a faster titration) and even [--] weeks in P3 (with optimized titration so it will not get any better than this) all while demonstrating a more favorable safety profile across adverse events. Moreover oral VK may deliver an even stronger efficacy and safety profile once optimized titration schedules are applied (more on titration in a future post). By contrast orfo P3 results"
[X Link](https://x.com/anyuser/status/1960030346705355076) 2025-08-25T17:23Z [----] followers, 35.8K engagements
"$VKTX ✔ $VKTX Having P2 data for both the oral and SC formulations makes it possible to identify true equivalences between treatment arms based on actual trial outcomes. When plotting WL against each GI adverse event several important insights emerge ones that (at least to my https://t.co/Hls31Plvra $VKTX Having P2 data for both the oral and SC formulations makes it possible to identify true equivalences between treatment arms based on actual trial outcomes. When plotting WL against each GI adverse event several important insights emerge ones that (at least to my https://t.co/Hls31Plvra"
[X Link](https://x.com/anyuser/status/1959321645627421025) 2025-08-23T18:27Z [---] followers, [---] engagements
"$VKTX Having P2 data for both the oral and SC formulations makes it possible to identify true equivalences between treatment arms based on actual trial outcomes. When plotting WL against each GI adverse event several important insights emerge ones that (at least to my knowledge the market has completely overlooked) as I havent seen anyone comment on them yet: [--]. After adjusting for placebo it becomes clear that the real equivalences are between: oral [--] mg and SC [---] mg oral [--] mg and SC [--] mg oral [---] mg and SC [--] mg The similarity in both efficacy and safety across these matched arms is"
[X Link](https://x.com/anyuser/status/1959178744079229373) 2025-08-23T08:59Z [----] followers, 42.3K engagements
"$VKTX ✅ @MeadowCapital @MeadowCapital- I have many thoughts on the $VKTX agreement with Corden. Mainly it is exceptionally positive for Viking. This deal gives VKTX multi metric ton/multi billion $ sales potential at "typical pharma margins" for what amounts to a zero dollar capital investment given @MeadowCapital @MeadowCapital- I have many thoughts on the $VKTX agreement with Corden. Mainly it is exceptionally positive for Viking. This deal gives VKTX multi metric ton/multi billion $ sales potential at "typical pharma margins" for what amounts to a zero dollar capital investment given"
[X Link](https://x.com/anyuser/status/1900370099237761080) 2025-03-14T02:15Z [---] followers, [---] engagements
"@MeadowCapital- I have many thoughts on the $VKTX agreement with Corden. Mainly it is exceptionally positive for Viking. This deal gives VKTX multi metric ton/multi billion $ sales potential at "typical pharma margins" for what amounts to a zero dollar capital investment given the $150 mill will be applied to product purchase. Unreal. Kudos to Brian Lian (and Greg Zante) for making this happen. I didn't think Corden was a potential partner because I thought LLY would have locked them into a non-compete before contracting them to make TRZ. Well clearly that was not the case. I'm guessing"
[X Link](https://x.com/anyuser/status/1900149518986875154) 2025-03-13T11:38Z [----] followers, [----] engagements
"$VKTX ✅ The value proposition of Viking is being put on the map again with Phase [--] Oral & Phase [--] SQ ready - assets if this partnership is worth 5.3B ✔ $lly $VKTX $NVO $RHHBY tell me you're drug not achieving good WL without telling me https://t.co/5yefi3af6o $lly $VKTX $NVO $RHHBY tell me you're drug not achieving good WL without telling me https://t.co/5yefi3af6o"
[X Link](https://x.com/anyuser/status/1899772556804038985) 2025-03-12T10:40Z [---] followers, [---] engagements
"$lly $VKTX $NVO $RHHBY tell me you're drug not achieving good WL without telling me https://endpts.com/roches-cardiometabolic-chief-warns-against-weight-loss-obsession-with-glp-1s/ https://endpts.com/roches-cardiometabolic-chief-warns-against-weight-loss-obsession-with-glp-1s/"
[X Link](https://x.com/anyuser/status/1880254979497455983) 2025-01-17T14:04Z [----] followers, 10.1K engagements
"$VKTX Absolutely back the strategy of B.L. & the BOD to set the floor- reduce the float- and make shorts try and play the longer game w/ Phase [--] oral data coming circa August. Punchbowl 🍷 has been taken from the shorts ✅ BTW: Like whom they hired to run the 250M ✔"
[X Link](https://x.com/anyuser/status/1895570070899999046) 2025-02-28T20:21Z [---] followers, [----] engagements
"$VKTX ✅ Buckle up - this is going to be very interesting regarding strategy and timing from the Brass at Viking ✔ Really like the move by CEO & BOD ✔ $VKTX buy back and what it could mean BTW I had a feeling the delayed 10K was going to be meaningful novice investors and bears didn't get it. A Pre-commercial biotech company buying back stock is very rare. Someone called $VKTX a scam yesterday if that's the case than $VKTX buy back and what it could mean BTW I had a feeling the delayed 10K was going to be meaningful novice investors and bears didn't get it. A Pre-commercial biotech company"
[X Link](https://x.com/anyuser/status/1894926988885782712) 2025-02-27T01:46Z [---] followers, [----] engagements
"$VKTX buy back and what it could mean BTW I had a feeling the delayed 10K was going to be meaningful novice investors and bears didn't get it. A Pre-commercial biotech company buying back stock is very rare. Someone called $VKTX a scam yesterday if that's the case than they'd have to be the dumbest scammers is history. Here are a few things to consider Yes this could simply be a testament of their Cash Reserves but for them to buy stock in a critical phase in their development a phase likely to be the most expensive in their Hx usually requiring cash reserves it makes me wonder if it's a sign"
[X Link](https://x.com/anyuser/status/1894922530877841436) 2025-02-27T01:28Z [----] followers, 31.7K engagements
"$VKTX ✅ $Abbv $PFE $MRK $NVo $VKTX $GPCR People tend to focus on Pfizer and Merck for obesity M&A obviously all BP likely looking at Lilly and novo success and market size. But one that is unfairly dropped from discussions is Abbvie. They are known to make sudden bold moves and outbid $Abbv $PFE $MRK $NVo $VKTX $GPCR People tend to focus on Pfizer and Merck for obesity M&A obviously all BP likely looking at Lilly and novo success and market size. But one that is unfairly dropped from discussions is Abbvie. They are known to make sudden bold moves and outbid"
[X Link](https://x.com/anyuser/status/1894590745379541042) 2025-02-26T03:30Z [---] followers, [---] engagements
"$Abbv $PFE $MRK $NVo $VKTX $GPCR People tend to focus on Pfizer and Merck for obesity M&A obviously all BP likely looking at Lilly and novo success and market size. But one that is unfairly dropped from discussions is Abbvie. They are known to make sudden bold moves and outbid all. Often with good follow up success and occasionally failure as happened recently Abbvie. CEO at JPM I think overall we have a very strong M&A track record. That said there's a large market with high unmet need and we see a differentiation that we can drive. We've proven in the past we've entered markets like you"
[X Link](https://x.com/anyuser/status/1894561511395529016) 2025-02-26T01:33Z [----] followers, 24.1K engagements
"$VKTX $PFE @BenzyStocks There are dozens of clues about Pfizer interest in Viking last few weeks ( I and others summarized ) . It is a fact that doesnt need a rumor. The main issue is the value gap and how they can resolve that. Viking CEO will not sell less than $20 B ( watching this guy for years @BenzyStocks There are dozens of clues about Pfizer interest in Viking last few weeks ( I and others summarized ) . It is a fact that doesnt need a rumor. The main issue is the value gap and how they can resolve that. Viking CEO will not sell less than $20 B ( watching this guy for years"
[X Link](https://x.com/anyuser/status/1893400884744220913) 2025-02-22T20:42Z [---] followers, [---] engagements
"There are dozens of clues about Pfizer interest in Viking last few weeks ( I and others summarized ) . It is a fact that doesnt need a rumor. The main issue is the value gap and how they can resolve that. Viking CEO will not sell less than $20 B ( watching this guy for years ) . Probably some SP appreciation due to rumors and speculations would help both parties . ( and also some competition on deal by others including NVO that could hurt a lot from such deal )"
[X Link](https://x.com/anyuser/status/1893341871952609765) 2025-02-22T16:47Z [----] followers, [----] engagements
"$VKTX ✅ Truist $VKTX Joon Lee hosting mgmnt for a virtual NDR on Friday 2/21. Truist $VKTX Joon Lee hosting mgmnt for a virtual NDR on Friday 2/21"
[X Link](https://x.com/anyuser/status/1892539527190778195) 2025-02-20T11:39Z [---] followers, [---] engagements
"Truist $VKTX Joon Lee hosting mgmnt for a virtual NDR on Friday 2/21"
[X Link](https://x.com/anyuser/status/1887875834087661606) 2025-02-07T14:47Z 42.5K followers, 23.1K engagements
"$VKTX ✅ $VKTX There is big interest in oral VK2735. Phase [--] centers are not accepting new pts ( multiple sources ). Identified [---] pts in no time. We should hear about enrollment close soon. Suggest to me phase [--] enrollment should be record time likely within weeks rather than $VKTX There is big interest in oral VK2735. Phase [--] centers are not accepting new pts ( multiple sources ). Identified [---] pts in no time. We should hear about enrollment close soon. Suggest to me phase [--] enrollment should be record time likely within weeks rather than"
[X Link](https://x.com/anyuser/status/1892331995872497876) 2025-02-19T21:54Z [---] followers, [---] engagements
"$VKTX There is big interest in oral VK2735. Phase [--] centers are not accepting new pts ( multiple sources ). Identified [---] pts in no time. We should hear about enrollment close soon. Suggest to me phase [--] enrollment should be record time likely within weeks rather than months"
[X Link](https://x.com/anyuser/status/1892295244361916775) 2025-02-19T19:28Z [----] followers, [----] engagements
"$VKTX ✅ $VKTX Upcoming Investor Events. Viking management will participate in the following upcoming investor events: Oppenheimer 35th Annual Healthcare Life Sciences Conference Virtual February [--] [--] [----] $VKTX Upcoming Investor Events. Viking management will participate in the following upcoming investor events: Oppenheimer 35th Annual Healthcare Life Sciences Conference Virtual February [--] [--] 2025"
[X Link](https://x.com/anyuser/status/1887989179851882644) 2025-02-07T22:17Z [---] followers, [---] engagements
"$VKTX Upcoming Investor Events. Viking management will participate in the following upcoming investor events: Oppenheimer 35th Annual Healthcare Life Sciences Conference Virtual February [--] [--] 2025"
[X Link](https://x.com/anyuser/status/1887981178335953173) 2025-02-07T21:46Z [----] followers, [----] engagements
"$VKTX ✅ $VKTX $PFE $NVO $LLy Viking. Raymond James increased prices target $125. Strong buy https://t.co/7uHV5nJikX $VKTX $PFE $NVO $LLy Viking. Raymond James increased prices target $125. Strong buy https://t.co/7uHV5nJikX"
[X Link](https://x.com/anyuser/status/1887482860048642450) 2025-02-06T12:45Z [---] followers, [---] engagements
"$VKTX $PFE $NVO $LLy Viking. Raymond James increased prices target $125. Strong buy"
[X Link](https://x.com/anyuser/status/1887481961360293911) 2025-02-06T12:42Z [----] followers, 32K engagements
"$VKTX ✅ $vktx $LLY $NVO $pFe Oppenheimer Viking. EC preview .manufacturing agreement that will support multi billion commercial opportunity. No issue in phase [--] https://t.co/FYbmdPLD97 $vktx $LLY $NVO $pFe Oppenheimer Viking. EC preview .manufacturing agreement that will support multi billion commercial opportunity. No issue in phase [--] https://t.co/FYbmdPLD97"
[X Link](https://x.com/anyuser/status/1886903180564340917) 2025-02-04T22:22Z [---] followers, [---] engagements
"$vktx $LLY $NVO $pFe Oppenheimer Viking. EC preview .manufacturing agreement that will support multi billion commercial opportunity. No issue in phase 3"
[X Link](https://x.com/anyuser/status/1886755532884603028) 2025-02-04T12:35Z [----] followers, 21.6K engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
@willjohn1517 Elevator_Up ⬆️Elevator_Up ⬆️ posts on X about $vktx, $nvo, $lly, $pfe the most. They currently have [-----] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.
Social category influence stocks finance currencies celebrities us election countries cryptocurrencies travel destinations
Social topic influence $vktx #44, $nvo, $lly, $pfe, ceo, novo, nvo, investment, glp1, company
Top accounts mentioned or mentioned by @gmeshortsqueeze @stocktwits @wallstreetbets @sbarron1950 @elonmusk @benzystocks @bioinvestor24 @mizuhoamericas @grassosteve @carterbworth @timseymour @timmypuffedit @semodough @wallstlobo @maziardoustdar @albertbourla @meadowcapital @biotech2k1 @theguruyouknow @ryansttrader
Top assets mentioned Viking Therapeutics, Inc (VKTX) Novo-Nordisk (NVO) Eli Lilly and Company (LLY) Pfizer, Inc. (PFE) GLP1 (GLP1) Merck & Co., Inc. (MRK) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Nash (NEX) Hims & Hers Health, Inc. (HIMS) AbbVie Inc (ABBV) Structure Therapeutics Inc. (GPCR) Iovance Biotherapeutics, Inc. Common Stock (IOVA) AstraZeneca PLC (AZN) Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Treasure (MAGIC) Evan (EVAN) Viking Holdings Ltd (VIK)
Top posts by engagements in the last [--] hours
"@Biotech2k1 $LLY is a bubble stock. Now thats an interesting interpretation. Whats its MC What Big Fish own huge stakes in the Company How long has it been an established Co. trading on the Stock exchange Cmon man - do better than that if you have a bear thesis- please ✔ $VKTX ✅"
X Link 2024-11-25T12:16Z [---] followers, [---] engagements
"$VKTX $PFE @BenzyStocks There are dozens of clues about Pfizer interest in Viking last few weeks ( I and others summarized ) . It is a fact that doesnt need a rumor. The main issue is the value gap and how they can resolve that. Viking CEO will not sell less than $20 B ( watching this guy for years @BenzyStocks There are dozens of clues about Pfizer interest in Viking last few weeks ( I and others summarized ) . It is a fact that doesnt need a rumor. The main issue is the value gap and how they can resolve that. Viking CEO will not sell less than $20 B ( watching this guy for years"
X Link 2025-02-22T20:42Z [---] followers, [---] engagements
"@TheGuruYouKnow $VKTX ✅ $VKTX Adding context to the type of sale: What is a 10b5-1 plan https://www.chase.com/personal/investments/learning-and-insights/article/stock-under-a-10b5-1-plan https://www.chase.com/personal/investments/learning-and-insights/article/stock-under-a-10b5-1-plan"
X Link 2024-10-27T12:28Z [---] followers, [---] engagements
"$VKTX Posters #17 & #18 to be presented on 11/3 at 7:30p CST They are readouts for VK [----] (GLP-1/GIP) - - Studies. ✅ #OW2024"
X Link 2024-10-28T08:40Z [---] followers, [---] engagements
"$VKTX ✅ $LLY $NOV Clear articulation of the key points regarding the Compounding Pharmacy issue - r/t the FDA Shortage List designation. Very Big money is involved. 💰 Lawsuit by Big Pharma in place. ✔ https://finance.yahoo.com/news/why-compounders-and-telehealth-providers-are-undeterred-by-the-potential-end-of-the-weight-loss-drug-shortage-154743126.html https://finance.yahoo.com/news/why-compounders-and-telehealth-providers-are-undeterred-by-the-potential-end-of-the-weight-loss-drug-shortage-154743126.html"
X Link 2024-10-28T10:21Z [---] followers, [---] engagements
"$VKTX ✅ The concerns of quality have been long-standing Novo Nordisk recently provided a study looking at compounded versions of its drug which have caused [--] deaths and [---] hospitalizations or adverse reactions between October [----] and June 2024.) https://finance.yahoo.com/news/why-compounders-and-telehealth-providers-are-undeterred-by-the-potential-end-of-the-weight-loss-drug-shortage-154743126.html https://finance.yahoo.com/news/why-compounders-and-telehealth-providers-are-undeterred-by-the-potential-end-of-the-weight-loss-drug-shortage-154743126.html"
X Link 2024-10-28T10:26Z [---] followers, [---] engagements
"@RyanSTTrader Its hard to fight against great molecules (VK2735 & VK2809) & a CEO who plays an adept game of Chess - for about [--] years. But we all have a certain destiny I guess $VKTX ✅ https://vikingtherapeutics.com/pipeline/overview/ https://vikingtherapeutics.com/pipeline/overview/"
X Link 2024-10-31T09:57Z [---] followers, [---] engagements
"@bioinvestor24 Thanks for the assessment of the comparative study info - to date. $VKTX ✅"
X Link 2024-11-01T00:31Z [---] followers, [---] engagements
"$VKTX ✅ / $IOVA ✅ $IOVA - When I decided to use my [--] years of pharma experience to identify biotech companies to invest last October of [----] I already had about [--] companies that I wanted to look into. The first one that I announced to you was $VKTX in December [----]. I got in at $11.65. I https://t.co/4QYl2W7rfc $IOVA - When I decided to use my [--] years of pharma experience to identify biotech companies to invest last October of [----] I already had about [--] companies that I wanted to look into. The first one that I announced to you was $VKTX in December [----]. I got in at $11.65. I"
X Link 2024-11-02T17:10Z [---] followers, [---] engagements
"@bioinvestor24 @lfilipecastro Novo Nordisk recently provided a study looking at compounded versions of its drug which have caused [--] deaths and [---] hospitalizations or adverse reactions between October [----] and June 2024"
X Link 2024-11-02T21:54Z [---] followers, [--] engagements
"$VKTX ✅ Embargo ✅ Abstracts are embargoed from media coverage until [--] PM Eastern Time on November [--] [----]. Site to Bookmark: https://obesityweek.org/attend/journalabstracts/ https://obesityweek.org/abstracts/embargo-policy/ https://obesityweek.org/attend/journalabstracts/ https://obesityweek.org/abstracts/embargo-policy/"
X Link 2024-11-03T02:49Z [---] followers, 15.8K engagements
"$VKTX ✅- Analyst seems grounded in his comments regarding the Obesity Space - and said he would recommend buying into the SP drop of Viking today. Speculation on Pharma like Merck either partnering / or a takeout for 2x the current MC was suggested. 💰 https://x.com/nims213/status/1853573831681626578s=46&t=1QcLBVu6e2vMgGHKOtW4Jg CNBCFastMoney: Viking Therapeutics tumbles 13% 📉 @MizuhoAmericas strategist Jared Holz breaks down the data. #Biotech #Markets. @grassosteve @CarterBWorth @timseymour offer their insights $VKTX https://t.co/OTBloE3zyG"
X Link 2024-11-04T23:41Z [---] followers, [---] engagements
"@CNBCFastMoney @MizuhoAmericas @grassosteve @CarterBWorth @timseymour $VKTX ✅ Data readout from #OW2024 vs other Pharma in the Obesity Space"
X Link 2024-11-04T23:53Z [---] followers, [---] engagements
"$VKTX ✅ Too simplistic as a thesis for a 13% drop. That said: I do believe that Viking announcing a partnership deal with a big Pharma / or an outright takeout has increased odds due to VK2735 efficacy/ tolerability data from recent Study results for the oral/ & SQ"
X Link 2024-11-05T08:32Z [---] followers, [---] engagements
"$VKTX ✅ #OW2024 - post conference data release &13% pullback of SP. More speculation on the why Bottom line of Yahoo Analysis- VK2735 validated efficacy/ tolerability from data and has value to a Big Pharma for possible M&A deal. ✔ 💰 https://finance.yahoo.com/video/viking-therapeutics-stock-falling-amid-210056194.htmlcontentType=VIDEO https://finance.yahoo.com/video/viking-therapeutics-stock-falling-amid-210056194.htmlcontentType=VIDEO"
X Link 2024-11-05T09:15Z [---] followers, [---] engagements
"@sbarron1950 @GMEshortsqueeze @Stocktwits @wallstreetbets $VKTX ✅ 💰 Bookmarked this on 11/6/24 circa 2:15p. Current SP in graphic & MC is 7.21B. Ill get back to you when this goes over [--] or would you prefer over 100per share so you can apologize to Mr. Lian. 😄 This is a set it and forget it goldmine in the making. ✔"
X Link 2024-11-06T19:22Z [---] followers, [---] engagements
"$VKTX ✅ VK2809 $VKTX next big catalyst is literally [--] weeks away have people forgetten they have MASH/NASH/Fibrosis drug VK2809 with a late breaker oral presentation at the Liver Meeting on Nov.19 $MDGL Redzdiffra only approved MASH drug on market big unmet need https://t.co/dACtmXCEds $VKTX next big catalyst is literally [--] weeks away have people forgetten they have MASH/NASH/Fibrosis drug VK2809 with a late breaker oral presentation at the Liver Meeting on Nov.19 $MDGL Redzdiffra only approved MASH drug on market big unmet need https://t.co/dACtmXCEds"
X Link 2024-11-07T10:13Z [---] followers, [---] engagements
"@Davel3098534103 I dont do PTs Staying long for the big payout. These molecules given the projected TAM for GLP-1 Co-Agonists in this same class is a goldmine 💰 $VKTX ✅"
X Link 2024-11-07T13:16Z [---] followers, [---] engagements
"$VKTX ✅ Wall Street dealmakers and corporate leaders expect the flood gates to open on merger and acquisition activity after President-elect Donald Trump takes office in January. https://www.cnbc.com/2024/11/07/wall-street-expects-trump-presidency-will-unlock-deal-making.html__source=iosappshare%7Ccom.google.chrome.ios.OpenExtension https://www.cnbc.com/2024/11/07/wall-street-expects-trump-presidency-will-unlock-deal-making.html__source=iosappshare%7Ccom.google.chrome.ios.OpenExtension"
X Link 2024-11-07T18:33Z [---] followers, [---] engagements
"$VKTX #2 ✔ One top dealmaker expected an M & A uptick broadly but agreed that pharmaceuticals and the financial sector were particularly poised for a resurgence. https://www.cnbc.com/2024/11/07/wall-street-expects-trump-presidency-will-unlock-deal-making.html__source=iosappshare%7Ccom.google.chrome.ios.OpenExtension https://www.cnbc.com/2024/11/07/wall-street-expects-trump-presidency-will-unlock-deal-making.html__source=iosappshare%7Ccom.google.chrome.ios.OpenExtension"
X Link 2024-11-07T18:48Z [---] followers, [---] engagements
"@NickMor19396581 @kiantrades Good question Ive downloaded the app to listen but its saying you will be notified when the call begins $VKTX ✅"
X Link 2024-11-07T19:21Z [---] followers, [---] engagements
"For Sbarron: $VKTX ✅ Ive seen your history of posts r/t Viking and its quite apparent what your agenda is. So please quit the condescending - but rather help me calculate how much longs have made on this stock YTD carrying 5K shares Got a #"
X Link 2024-11-07T20:06Z [---] followers, [---] engagements
"@vxxvix $VKTX Sparky whats the source of this speculation since its placed in quotes Thanks Do you have a link ✔"
X Link 2024-11-07T20:41Z [---] followers, [----] engagements
"$VKTX ✅ $VKTX Thought provoking r/t the future of the Obesity Space- from 5/2024. ✔ The arrival of highly effective weight loss pharmacotherapies marked an inflection point for the obesity market. For the first time pharmacological interventions delivered meaningful I like this blog from @IQVIA_global (May 2024): When the dust settles: The future shape of the #obesity market. $NVO $LLY $ZEAL $GUBRA $VKTX $BIOA $AZN $RHHBY $PFE $AMGN $SRRK $BHVN $SKYE https://t.co/pmU7iO3N42 https://t.co/tweUQMESLC I like this blog from @IQVIA_global (May 2024): When the dust settles: The future shape of the"
X Link 2024-11-08T11:54Z [---] followers, [---] engagements
"@_TGiR Agree with Bioinvester (above) MC currently is 7.64B. I would think the minimum the CEO would except is about 3x current- circa [--] to 23B. That would be a SP at BO of 3x or circa $205 per share. Obviously - speculation- but I think its more towards fair value"
X Link 2024-11-09T01:34Z [---] followers, [---] engagements
"VKTX ✅ Yes Im sure that [--] out of [--] analysts that have a buy rating on Viking are all saying its based on a buyout scenario as well. Im calling out FUD - on this post below 👇 $VKTX for those blindly following a pharma guru peddling $VKTX buyout (who at most has predictions that are like coin toss having seen him for years) remember that his buys were much lower than what you would have now. so be prudent and dont blindly invest .jmo $VKTX for those blindly following a pharma guru peddling $VKTX buyout (who at most has predictions that are like coin toss having seen him for years) remember"
X Link 2024-11-09T01:44Z [---] followers, [--] engagements
"@BIOTECHENIGMA VKTX ✅ Yes Im sure that [--] out of [--] analysts that have a buy rating on Viking are all saying its based on a buyout scenario as well. Is that your understanding Im calling out FUD - on this post above. ✔"
X Link 2024-11-09T01:49Z [---] followers, [--] engagements
"$VKTX ✅ Yes for all the number crunchers its certainly about ROI. It would obviously be projections -but in healthcare its been an acceptable concept to secure bids on contracts called by various names- one of which is a predictive model. 💰 https://www.thestreet.com/lifestyle/health/new-healthcare-policy-changes-will-soon-affect-weight-loss-drugs https://www.thestreet.com/lifestyle/health/new-healthcare-policy-changes-will-soon-affect-weight-loss-drugs"
X Link 2024-11-09T08:33Z [---] followers, [--] engagements
"United Healthcare whose parent Company is (UHG) uses it to win bids in a lucrative field termed Disease Management. As AI takes hold more and more in health care- it will be believable- this type of ROI (Return on Investment) for Government dollars. ✔ $VKTX ✅💰"
X Link 2024-11-09T08:36Z [---] followers, [--] engagements
"$VKTX ✅ - Comparatives going forward will be both interesting & and a positive for attracting investment dollars. 💰 This week I have been digesting $NVO q3 [----] earnings report and I remain excited for the future ahead. My main interest being CagriSema and the potential it has. I want to see how it tops competitive drugs from $LLY and now $VKTX. Theres much upside in terms of valuation https://t.co/SueBSQ1Fxw This week I have been digesting $NVO q3 [----] earnings report and I remain excited for the future ahead. My main interest being CagriSema and the potential it has. I want to see how it"
X Link 2024-11-09T08:46Z [---] followers, [---] engagements
"$VKTX ✅ Its likely we will hear increasingly r/t the GLP-1 discussions - - the manufacturing theme of peptides. ie: VK2735 It doesnt hurt to stay informed on some of the significant angles of this - - if interested. ✔ https://www.rootsanalysis.com/reports/peptide-therapeutics-manufacturing/305.html https://www.rootsanalysis.com/reports/peptide-therapeutics-manufacturing/305.html"
X Link 2024-11-11T11:12Z [---] followers, [---] engagements
"$VKTX ✅ Question 3: What are the top peptide drugs by sales Answer: The top peptide therapeutics by sales are Ozempic (semaglutide) Rybelsus (semaglutide) Wegovy (semaglutide) Trulicity (dulaglutide) Mounjaro (tirzepatide) and Saxenda (liraglutide)"
X Link 2024-11-11T11:28Z [---] followers, [---] engagements
"$VKTX ✅ Sbarron shortsighted as usual ✔ With that in mind Merck has ample cash on hand to forge deals w/ management expressing an appetite for assets across all stages of clinical development according to Leerinks M&A report. Deals is plural https://www.fiercepharma.com/pharma/bms-merck-amgen-and-more-must-pursue-ma-offset-looming-patent-lapses-leerink https://www.fiercepharma.com/pharma/bms-merck-amgen-and-more-must-pursue-ma-offset-looming-patent-lapses-leerink"
X Link 2024-11-14T13:16Z [---] followers, [---] engagements
"@timmypuffedit @notmrmanziel $VKTX ✅ Better to do DD before spouting a vacant phrase or [--] One CEO- who has banked some 💰 from this 💎 stock and still owns over 2M shares. Hows that for skin in the game You also forgot to mention hes the founder going back to [----]. ✔ Facts are better than drivel. ✔"
X Link 2024-11-14T17:54Z [---] followers, [---] engagements
"$VKTX Adjudicated death from CV causes or a worsening HF event occurred in [--] PTs (9.9%) in the tirzepatide grp & in [--] PTs (15.3%) in the placebo grp (hazard ratio 0.62; 95% confidence interval CI [----] to 0.95; P=0.026). Tirzepatide for HF w/ Preserved EF & Obesity"
X Link 2024-11-16T16:52Z [---] followers, [---] engagements
"$VKTX ✅ $LLY $NVO $VKTX Treatment with tirzepatide led to a lower risk of a composite of death from cardiovascular causes or worsening heart failure than placebo and improved health status in patients with heart failure with preserved ejection fraction and obesity. $LLY $NVO $VKTX Treatment with tirzepatide led to a lower risk of a composite of death from cardiovascular causes or worsening heart failure than placebo and improved health status in patients with heart failure with preserved ejection fraction and obesity"
X Link 2024-11-17T09:21Z [---] followers, [---] engagements
"$VKTX ✅ Making America Healthy Again One Quarter Pounder at a time 👀😂 Save one for me - Bobby 😋 👀👀 https://t.co/bxP7M0iRU5 👀👀 https://t.co/bxP7M0iRU5"
X Link 2024-11-17T12:20Z [---] followers, [---] engagements
"$VKTX ✅ $VKTX approaching a price where their market cap reflects them only taking 1% of the $100B obesity market TAM and 0% of the NASH $30B TAM in [----] despite having the best drugs on the market.good times. $VKTX approaching a price where their market cap reflects them only taking 1% of the $100B obesity market TAM and 0% of the NASH $30B TAM in [----] despite having the best drugs on the market.good times"
X Link 2024-11-18T09:24Z [---] followers, [---] engagements
"$VKTX ✅ @GMEshortsqueeze @Stocktwits @wallstreetbets - Sbarron is a bag of hot air $MDGL has a MC of 6.6B & its primary asset is MGL-3196 - is used for NASH. ✔ Viking will enter Phase [--] w/ VK2809. VKTX also has VK2735 which SQ - for Obesity Phase [--] in [----] ✔💰"
X Link 2024-11-19T12:47Z [---] followers, [---] engagements
"$VKTX ✅ 💰 BTW: Somebody please let the dude know -who is usurping my time w/ thoughts about Viking only being worth circa $10 pps - that Ive given him a cheat sheet for the lack of DD below 👇 👇 Patience for the savvy investor in Viking will pay handsomely in the long run. $VKTX CEO "bulk of the value in our view is the injectable in the foreseeable future" as an induction for weight loss and transitioning to monthly subq or oral weekly. A very convenient regimen. $VKTX CEO "bulk of the value in our view is the injectable in the foreseeable future" as an induction for weight loss and"
X Link 2024-11-20T00:30Z [---] followers, [----] engagements
"$VKTX ✅ $VKTX A lot of fake experts on X talk about "manufacturing challenges." But here's the official $VKTX line: 📍They reduced exposure to drug & patients MAINTAINED weight loss 📍That means LESS manufacturing will be needed 📍Speaking to multiple suppliers about "multi-ton" deals https://t.co/Ry6ptaVSRW $VKTX A lot of fake experts on X talk about "manufacturing challenges." But here's the official $VKTX line: 📍They reduced exposure to drug & patients MAINTAINED weight loss 📍That means LESS manufacturing will be needed 📍Speaking to multiple suppliers about "multi-ton" deals"
X Link 2024-11-20T07:52Z [---] followers, [---] engagements
"@anni_sen Scott is the professional that should be leading the FDA again. He made the most sense of any authority during the COVID pandemic. I wish @realDonaldTrump & @elonmusk would pow wow with this guy $VKTX ✅"
X Link 2024-11-20T17:52Z [---] followers, [---] engagements
"@Idvst8_Markets Thanks $VKTX ✅"
X Link 2024-11-21T09:30Z [---] followers, [---] engagements
"@GMEshortsqueeze @wallstreetbets @Stocktwits $VKTX ✅ 💰 B. Riley analyst Mayank Mamtani initiated coverage of Viking Therapeutics (VKTX) with a Buy rating and $109 price target The firm has confidence in the long-term disruptive potential of the companys lead program VK2735"
X Link 2024-11-22T10:54Z [---] followers, [---] engagements
"@elonmusk Thanks - Elon & Vivek ✔ $VKTX ✅ Here are some general thoughts related to this topic. ✔"
X Link 2024-11-22T11:29Z [---] followers, [---] engagements
"$VKTX ✅ $VKTX Viking stands out as the only developer of a GLP-1/GIP dual agonist designed for both induction and maintenance therapy the analyst notes. Additionally B. Riley emphasizes that Viking has delivered a best-in-class oral dataset so far this year. $VKTX Viking stands out as the only developer of a GLP-1/GIP dual agonist designed for both induction and maintenance therapy the analyst notes. Additionally B. Riley emphasizes that Viking has delivered a best-in-class oral dataset so far this year"
X Link 2024-11-22T17:28Z [---] followers, [----] engagements
"$VKTX ✅ Careful Adam - Viking has been green lately- now 50s and then 60s ✔ As Dylan sang: And don't speak too soon For the wheel's still in spin And there's no tellin' who That it's namin' For the loser now Will be later to win For the times they are a-changin' 🎶 $VKTX Now whats the catalyst to pull it out of a downward drift back to the $40s where it recently traded https://t.co/Pe5LXvUkIC $VKTX Now whats the catalyst to pull it out of a downward drift back to the $40s where it recently traded https://t.co/Pe5LXvUkIC"
X Link 2024-11-23T12:13Z [---] followers, [---] engagements
"$VKTX ✅ [--] Monster Stocks in the Making: (Viking): Weight-loss management is the hottest therapeutic area in the pharmaceutical industry right now. Although the companies dominating the field are the usual suspects a notable mid-cap biotech is VKTX ✔ https://finance.yahoo.com/news/3-monster-stocks-making-113000110.html https://finance.yahoo.com/news/3-monster-stocks-making-113000110.html"
X Link 2024-11-24T11:58Z [---] followers, [---] engagements
"$VKTX ✅ Cory Renauer The Motley Fool 11/25/24 Key Takeaways Billionaire Ken Griffins hedge fund Citadel has invested $93 million in Viking a clinical-stage drugmaker that could see its stock price rise 105% according to a Wall Street analyst. https://finance.yahoo.com/news/billionaire-ken-griffin-invested-93-092100240.html https://finance.yahoo.com/news/billionaire-ken-griffin-invested-93-092100240.html"
X Link 2024-11-25T11:02Z [---] followers, [----] engagements
"$VKTX ✅ In the third quarter Griffin and Citadel more than tripled its stake in Viking Therapeutics. Griffin isnt the only one enthusiastic about this clinical-stage drugmaker. Wall Street analysts are sticking their necks out and predicting big gains around the corner.✔💰"
X Link 2024-11-25T11:07Z [---] followers, [----] engagements
"@timmypuffedit Yeah please short Viking into EOY 2025- Ill thank you for your money 💰 $VKTX ✅"
X Link 2024-11-25T14:17Z [---] followers, [---] engagements
"$VKTX ✅ $LLY Mounjaro TRx/NRx scripts for the week of 11/15/2024 were 436500/229400 (vs. 443100/233600 last week) per IQVIA data. Zepbound TRx/NRx scripts were 191000/137200 (vs. 190500/138300 last week). $NVO $VKTX $LLY Mounjaro TRx/NRx scripts for the week of 11/15/2024 were 436500/229400 (vs. 443100/233600 last week) per IQVIA data. Zepbound TRx/NRx scripts were 191000/137200 (vs. 190500/138300 last week). $NVO $VKTX"
X Link 2024-11-25T14:27Z [---] followers, [---] engagements
"$VKTX ✅ @GMEshortsqueeze @Stocktwits @wallstreetbets SBarron1950. Blah Blah. ✔ As usual failed to mention the CEO holds over 2M shares & calculate that times the current SP ✔ BTW: it was green today in case you were wondering - 🤓"
X Link 2024-11-26T21:23Z [---] followers, [---] engagements
"@Simsalabim2022 Ok - so this a did you know segment To stay with the juvenile tenor of your postLOL 😂 Vikes has 88% Institutional ownership vs 86% Tern - LOL 😂✔ $VKTX ✅ BTW any phase [--] molecule starting up soon for obesity"
X Link 2024-11-26T21:54Z [---] followers, [---] engagements
"$VKTX $AMGN ✅ Amgen seems to be sinking in a lot of sweat and treasure into an Obesity candidate that has poor tolerability ✔ And to piecemeal the unveiling of a full data readout is a bush league strategy. In the end it will likely come back to bite them- w/ no ROI ✔ $AMGN $LLY $NVO $VKTX JP Morgan. Vomiting remained at 40% https://t.co/rzLuYXmEpo $AMGN $LLY $NVO $VKTX JP Morgan. Vomiting remained at 40% https://t.co/rzLuYXmEpo"
X Link 2024-11-27T03:49Z [---] followers, [---] engagements
"$VKTX $LLY $NVO ✅ The proposed Medicare and Medicaid changes may be only the beginning analysts said. This marks a major evolution in the treatment of obesity as a disease said Evan Seigerman an analyst at BMO Capital Markets ✔ https://finance.yahoo.com/news/biden-proposes-medicare-medicaid-coverage-104108202.html https://finance.yahoo.com/news/biden-proposes-medicare-medicaid-coverage-104108202.html"
X Link 2024-11-27T10:40Z [---] followers, [---] engagements
"$VKTX ✅ Evan Seigerman - We are starting to see the US healthcare system shift how it thinks about the treatment of metabolic disease moving from the long-held view that obesity was a lifestyle condition to the recognition that metabolic disease deserves real treatment. ✔"
X Link 2024-11-27T10:43Z [---] followers, [---] engagements
"$VKTX $AMGN ✅ $VKTX Raymond James calling $AMGN out for the wild obfuscation of their data yesterday. When I was in Uni my professor would have chewed up me and spat me out for doing that. "What is this amateur hour No Y-Axis Every child knows to label their data" https://t.co/XSJ1jJDY11 $VKTX Raymond James calling $AMGN out for the wild obfuscation of their data yesterday. When I was in Uni my professor would have chewed up me and spat me out for doing that. "What is this amateur hour No Y-Axis Every child knows to label their data" https://t.co/XSJ1jJDY11"
X Link 2024-11-27T21:29Z [---] followers, [---] engagements
"@gurgavin $VKTX ✅"
X Link 2024-11-28T09:21Z [---] followers, [---] engagements
"$VKTX $NVO $LLY ✅ KEY FINDINGS Weight loss drugs are here to stay with 47% of respondents indicating that the impact of these treatments will be large and sustainable long term up from just 33% last year. https://www.reuters.com/business/healthcare-pharmaceuticals/healthcare-executives-expect-more-ipos-corporate-dealmaking-2025-2024-11-19/ https://www.reuters.com/business/healthcare-pharmaceuticals/healthcare-executives-expect-more-ipos-corporate-dealmaking-2025-2024-11-19/"
X Link 2024-11-28T11:52Z [---] followers, [---] engagements
"$VKTX $NVO ✅ CONTEXT Earlier in November Novo Nordisk's Wegovy weight-loss drug sales beat its forecast in an obesity drug market that some analysts forecast could be worth about $150 billion by the early 2030s. At the moment demand outweighs supply"
X Link 2024-11-28T11:55Z [---] followers, [---] engagements
"$VKTX ✅ Leerink;" $VKTX Lackluster MariTide Data Lift Competitive Overhang Boosting VK2735 Prospects; The results while nominally positive did not meet elevated investor expectations lifting a competitive overhang for $VKTX's (OP) VK2735 ('2735 GLP-1/GIP agonist) which we believe Leerink;" $VKTX Lackluster MariTide Data Lift Competitive Overhang Boosting VK2735 Prospects; The results while nominally positive did not meet elevated investor expectations lifting a competitive overhang for $VKTX's (OP) VK2735 ('2735 GLP-1/GIP agonist) which we believe"
X Link 2024-11-29T09:13Z [---] followers, [---] engagements
"$VKTX ✅ Obesity ✔ Now desperate $VKTX longs getting some doctor to say that obesity isnt a choice. Its a result of mental weakness and poor decisions. There should be no sympathy for fat people. Now desperate $VKTX longs getting some doctor to say that obesity isnt a choice. Its a result of mental weakness and poor decisions. There should be no sympathy for fat people"
X Link 2024-12-02T03:54Z [---] followers, [---] engagements
"$VKTX ✅ $LLY $NVO https://youtu.be/SmjVZYgyDx0si=Zak4F81S5qLpcmhA https://youtu.be/SmjVZYgyDx0si=Zak4F81S5qLpcmhA"
X Link 2024-12-03T03:29Z [---] followers, [---] engagements
"$VKTX $LLY $NVO ✅ BMO highlighted a positive outlook for Eli Lilly product sales leading up to the holiday season. Analysts observed a notable uptick in total & new prescriptions for Lilly - diabetes obesity treatments Mounjaro & Zepbound which saw increases of 4.5% & 5.7%"
X Link 2024-12-03T08:48Z [---] followers, [---] engagements
"$VKTX ✅ VA Under Secretary for Health Dr. Shereef Elnahal said roughly $2 billion of the $6.6 billion requested from Congress is needed for weight-loss drugs known as GLP-1 agonists & new medications for illnesses found in veterans such as MASH a fatty liver disease"
X Link 2024-12-03T08:55Z [---] followers, [---] engagements
"$VKTX ✅ Current - Projected value to BP: [--]. TAM for Obesity drugs going to 130-150B annually by [----]. ✔ $VKTX Current Market Sentiment [--]. Positive results already be "priced in" [--]. Concerns about commercial viability or regulatory hurdles might limit the upside [--]. Negative results can lead to a major loss in value $VKTX Current Market Sentiment [--]. Positive results already be "priced in" [--]. Concerns about commercial viability or regulatory hurdles might limit the upside [--]. Negative results can lead to a major loss in value"
X Link 2024-12-05T03:53Z [---] followers, [---] engagements
"$VKTX $LLY ✅ LONDON Dec [--] (Reuters) - Britains drugs cost-effectiveness watchdog NICE said on Thursday it will recommend the drug Mounjaro be made available to around [------] people in the country via the state health system over the next [--] years. https://www.reuters.com/business/healthcare-pharmaceuticals/britain-drug-cost-watchdog-says-it-will-recommend-lilly-obesity-drug-2024-12-05/ https://www.reuters.com/business/healthcare-pharmaceuticals/britain-drug-cost-watchdog-says-it-will-recommend-lilly-obesity-drug-2024-12-05/"
X Link 2024-12-05T04:42Z [---] followers, [---] engagements
"@KingJohnOfMasha @UpdateNews724 Yo - he was a health insurance CEO - Its amazing how much folks are just like parrots 🦜 it the mind and speech anymore - ✔"
X Link 2024-12-05T09:41Z [---] followers, [--] engagements
"$VKTX $LLY $NVO ✅ There are always exceptions to the rule as there are patients who lose weight with medication and then come off of it and keep the weight off but the overwhelming majority will need ongoing and chronic therapy they continued. https://www.freethink.com/biotech/obesity-rate-falling https://www.freethink.com/biotech/obesity-rate-falling"
X Link 2024-12-07T15:33Z [---] followers, [---] engagements
"$VKTX $LLY ✅ Eli Lilly the company that makes the blockbuster weight loss treatment Zepbound will start studying its obesity products as treatments for alcohol and drug abuse making it the first major drugmaker to do so CEO David Ricks✔💰 https://www.statnews.com/2024/12/10/eli-lilly-zepbound-alcohol-drug-abuse-david-ricks/ https://www.statnews.com/2024/12/10/eli-lilly-zepbound-alcohol-drug-abuse-david-ricks/"
X Link 2024-12-11T03:33Z [---] followers, [---] engagements
"$VKTX ✅ 1/ Over a century ago scientists uncovered a curious link between the gut & the pancreas. This sparked decades of research culminating in one of the greatest medical breakthroughs. This is the story of GLP-1 that I would like to share. 🧵 https://t.co/oW1XQSnmae 1/ Over a century ago scientists uncovered a curious link between the gut & the pancreas. This sparked decades of research culminating in one of the greatest medical breakthroughs. This is the story of GLP-1 that I would like to share. 🧵 https://t.co/oW1XQSnmae"
X Link 2024-12-11T05:00Z [---] followers, [---] engagements
"$VKTX $PFE ✅ We strongly urge you to vote against the confirmation of his appointment as Secretary of the DHHS. Signed [--] Nobel Laureates in Medicine Chemistry Physics & Economics ✔ https://www.cnbc.com/amp/2024/12/11/healthy-returns-novo-nordisk-catalent-deal-closer-to-closing.html https://www.cnbc.com/amp/2024/12/11/healthy-returns-novo-nordisk-catalent-deal-closer-to-closing.html"
X Link 2024-12-12T00:22Z [---] followers, [---] engagements
"$VKTX ✅ The post I'm quoting below by @BernardGoldste6 is outstanding 👏 has many good points on why a $VKTX has an increased probability for a near term buyout. I'm adding a few thoughts to what is quoted: There are many opportunities to maximize $VK2735 long term potential by The post I'm quoting below by @BernardGoldste6 is outstanding 👏 has many good points on why a $VKTX has an increased probability for a near term buyout. I'm adding a few thoughts to what is quoted: There are many opportunities to maximize $VK2735 long term potential by"
X Link 2024-12-12T11:18Z [---] followers, [---] engagements
"$VKTX ✅ Is Viking Therapeutics ( $VKTX ) Preparing for a Buyout Several signals suggest that a major acquisition could be on the horizon for Viking. Heres a breakdown of whats happening and why it matters: Is Viking Therapeutics ( $VKTX ) Preparing for a Buyout Several signals suggest that a major acquisition could be on the horizon for Viking. Heres a breakdown of whats happening and why it matters:"
X Link 2024-12-12T11:21Z [---] followers, [---] engagements
"$VKTX ✅ JUST NOW: Jim Cramer has exchange with RFK Jr. about Big Pharma vaccines CRAMER: "What do you think about GLP-1 drugs" RFK: "The best first thing is lifestyle: eating well making sure that you don't get obese. Those GLP drugs have a place." CRAMER: "A lot of people want to https://t.co/Vve0DEkAm7 JUST NOW: Jim Cramer has exchange with RFK Jr. about Big Pharma vaccines CRAMER: "What do you think about GLP-1 drugs" RFK: "The best first thing is lifestyle: eating well making sure that you don't get obese. Those GLP drugs have a place." CRAMER: "A lot of people want to"
X Link 2024-12-13T03:13Z [---] followers, [---] engagements
"@Lance_Edelman @EricLDaugh Simplistic conclusion- talk to obesity experts who have worked with populations of those with BMI over [--] and come smell the coffee. Eating well and exercising have their place Its amazing how humans are so given to 🦜 parroting a belief system for their tribe. ✅"
X Link 2024-12-13T03:19Z [---] followers, [----] engagements
"$VKTX ✅ Selling into the lap of Tutes 💰 Hmmm Institutional Shares (Long) [--------] - 89.11% (ex 13D/G) - change of 8.95MM shares 9.91% MRQ Institutional Value (Long) $ [-------] USD $VKTX Ive only heard of bigger pieces of shit than this dog $VKTX Ive only heard of bigger pieces of shit than this dog"
X Link 2024-12-13T10:15Z [---] followers, [---] engagements
"$VKTX ✅ Somebody please let @SBarron1950 know ✔ - they are all buying the CEO propaganda hmmm - you probably know more than all the Tutes. 😂 *** $8.3M worth for this vacuum cleaner LOL 💰 https://www.marketbeat.com/instant-alerts/stifel-financial-corp-acquires-62956-shares-of-viking-therapeutics-inc-nasdaqvktx-2024-12-13/ https://www.marketbeat.com/instant-alerts/stifel-financial-corp-acquires-62956-shares-of-viking-therapeutics-inc-nasdaqvktx-2024-12-13/"
X Link 2024-12-13T10:27Z [---] followers, [---] engagements
"$VKTX ✅ $NVO $VKTX - $BANB Bachem capacity to make #VK2735 for Viking has just increased. The reason is Bachem is down around 7% today on $NVO CagriSema news which means: ➡Clearly the market is assuming Bachem was going to be making the #Cagrilintide portion of #CagriSema for Novo. $VKTX - $BANB Bachem capacity to make #VK2735 for Viking has just increased. The reason is Bachem is down around 7% today on $NVO CagriSema news which means: ➡Clearly the market is assuming Bachem was going to be making the #Cagrilintide portion of #CagriSema for Novo"
X Link 2024-12-21T10:56Z [---] followers, [---] engagements
"$VKTX ✅ $LLY $LLY FDA approves Zepbound (tirzepatide) as the 1st and only Rx medicine for mod-severe obstructive sleep apnea in adults with obesity Adults taking Zepbound had at least [--] fewer breathing interruptions/hr. Up to 50% had [--] symptoms after [--] year. https://t.co/4madjowHEW $LLY FDA approves Zepbound (tirzepatide) as the 1st and only Rx medicine for mod-severe obstructive sleep apnea in adults with obesity Adults taking Zepbound had at least [--] fewer breathing interruptions/hr. Up to 50% had [--] symptoms after [--] year. https://t.co/4madjowHEW"
X Link 2024-12-21T11:02Z [---] followers, [---] engagements
"$VKTX $LLY ✅ Lilly obesity drug Mounjaro to be offered in Britains NHS after watchdog nod ✔ Mounjaro will be available through Britains state health system for some patients from March after the drugs cost-effectiveness watchdog NICE on Monday gave its blessing. ✔💰"
X Link 2024-12-23T22:28Z [---] followers, [---] engagements
"$VKTX ✅ $NVO $LLY $VKTX This Musk experience is an anecdote and cant be generalized but from efficacy perspective Mounjaro clearly wins over ozempic. Data from UK (self pay ) clearly show people preference for GLP1 GIP dual agonist . CagriSema doesnt seem to be the answer to Mounjaro https://t.co/JVJtk17ICT $NVO $LLY $VKTX This Musk experience is an anecdote and cant be generalized but from efficacy perspective Mounjaro clearly wins over ozempic. Data from UK (self pay ) clearly show people preference for GLP1 GIP dual agonist . CagriSema doesnt seem to be the answer to Mounjaro"
X Link 2024-12-26T11:03Z [---] followers, [---] engagements
"$VKTX ✅ $VKTX $NVO $AMGN If we dont hear Viking phase [--] start today Monday or Tuesday. It is almost certain BO or partnership of some sort . Sure the suppressed SP ( like all bios) argues against acquisition with very high premium and CEO last appearance at Stifel meeting didnt $VKTX $NVO $AMGN If we dont hear Viking phase [--] start today Monday or Tuesday. It is almost certain BO or partnership of some sort . Sure the suppressed SP ( like all bios) argues against acquisition with very high premium and CEO last appearance at Stifel meeting didnt"
X Link 2024-12-27T22:16Z [---] followers, [---] engagements
"$VKTX ✅ Happy new year My selection for a few promising Bios for [----] based on wide addressable market and competitive pipeline. Not including ones that address rare diseases given the highly special aspect of that and the failure risk . Not financial advice 1- $VKTX best in class Happy new year My selection for a few promising Bios for [----] based on wide addressable market and competitive pipeline. Not including ones that address rare diseases given the highly special aspect of that and the failure risk . Not financial advice 1- $VKTX best in class"
X Link 2025-01-02T21:41Z [---] followers, [----] engagements
"@ManOnThePen @elonmusk Buy $VKTX going into Phase [--] SQ to create competitive environment w/ Big Pharma like $LLY & $NVO - with a solid CDMO partnership- within [--] months- it could get to market ✅ Price will adjust. GLP/GIP Co-Agonist Agents have the best efficacy & tolerability to date ✔"
X Link 2025-01-03T21:13Z [---] followers, [----] engagements
"$VKTX ✅ @sbarron1950 @GMEshortsqueeze @Stocktwits @wallstreetbets #JPM2025 I know SBarron will want to hear Dr. Lian present on 1/13 - addressing the value of the pipeline- I.e. VK2735 & VK2809 BTW: He maintains over 2.4M shares - did you happen to mention that 🤓💰"
X Link 2025-01-07T00:53Z [---] followers, [---] engagements
"$VKTX ✅ CEO Brian Lian Ph.D. will deliver a corporate presentation ✔ 43rd Annual J.P. Morgan Healthcare Conference Dr. Lian will deliver a corporate presentation and participate in 1-on-1 meetings. Presentation Timing: 1:30 2:10 p.m. Pacific on Monday January [--] 2025"
X Link 2025-01-07T00:57Z [---] followers, [---] engagements
"$VKTX $NVO $LLY $AMGN ✅ Oral - VK2735 * In process now - watch how quickly [--] weeks goes - & FDA green light on next stage ✔ Mid year readout likely ✔ FDA agreement to PH3 is very plausible if the expected data readout remains on target w/ efficacy & tolerability. ✔ $VKTX $AMGN $NVO $LLY $RHHBY Come on guys .this is not speculation . It is reality. BL just met with the FDA. There is no way on earth that he did not ask them about the oral program. He must have confirmed that its OK to proceed with oral phase [--] after this phase [--] or he $VKTX $AMGN $NVO $LLY $RHHBY Come on guys .this is not"
X Link 2025-01-09T10:53Z [---] followers, [----] engagements
"$VKTX ✅ VK2735 $pfe $MRK $LLY $NVO $VKTX $Amgn Some CEOs continue to invoke next generation mechanisms in obesity Phase [--] trials clearly show by now that the best weight loss with tolerability balance comes from GLP1/GIP activation. CagriSema trial was phase [--] and clearly showed amylin is $pfe $MRK $LLY $NVO $VKTX $Amgn Some CEOs continue to invoke next generation mechanisms in obesity Phase [--] trials clearly show by now that the best weight loss with tolerability balance comes from GLP1/GIP activation. CagriSema trial was phase [--] and clearly showed amylin is"
X Link 2025-01-16T04:17Z [---] followers, [---] engagements
"$VKTX ✅ $NVO $LLY TX plan & Insurance coverage for GLP-1 Discussion ✔ Desperate for help. "Patient is hoping in their next blood work that they will have type [--] diabetes so that they will qualify for GLP1 therapies". I 100% understand why someone would feel this way and that is a sad reflection upon medicine. Desperate for help. "Patient is hoping in their next blood work that they will have type [--] diabetes so that they will qualify for GLP1 therapies". I 100% understand why someone would feel this way and that is a sad reflection upon medicine"
X Link 2025-01-16T04:53Z [---] followers, [---] engagements
"$VKTX One of the most promising contenders hoping to get in on the lucrative market is biotech Viking Therapeutics ✅ The company has an injectable weight-loss treatment starting late-stage clinical trials this year as well as an oral candidate in mid-stage trials. ✅ "
X Link 2025-01-23T13:55Z [---] followers, [----] engagements
"$VKTX ✅ $VKTX $LLY $NVO $GPCR $AMGN $PFE With tirzapetide leadership position in obesity it is tempting to predict wt loss from the [--] remaining primary drugs in phase [--] or entering phase [--]. Namely; VK2735 and retatrutide I made my predictions of Maritide and CagriSema within narrow $VKTX $LLY $NVO $GPCR $AMGN $PFE With tirzapetide leadership position in obesity it is tempting to predict wt loss from the [--] remaining primary drugs in phase [--] or entering phase [--]. Namely; VK2735 and retatrutide I made my predictions of Maritide and CagriSema within narrow"
X Link 2025-01-24T01:30Z [---] followers, [----] engagements
"$VKTX ✅ Buckle up - this is going to be very interesting regarding strategy and timing from the Brass at Viking ✔ Really like the move by CEO & BOD ✔ $VKTX buy back and what it could mean BTW I had a feeling the delayed 10K was going to be meaningful novice investors and bears didn't get it. A Pre-commercial biotech company buying back stock is very rare. Someone called $VKTX a scam yesterday if that's the case than $VKTX buy back and what it could mean BTW I had a feeling the delayed 10K was going to be meaningful novice investors and bears didn't get it. A Pre-commercial biotech company"
X Link 2025-02-27T01:46Z [---] followers, [----] engagements
"$VKTX ✅ $VKTX VK2735 subQ once a month [--] injections while the current drugs require [--] injections. This adds significant Value More affordability More convenience More efficacy More tolerability This asset alone and its potential justifies a much greater valuation than current $VKTX VK2735 subQ once a month [--] injections while the current drugs require [--] injections. This adds significant Value More affordability More convenience More efficacy More tolerability This asset alone and its potential justifies a much greater valuation than current"
X Link 2024-11-07T03:10Z [---] followers, [---] engagements
"$XBI is super frothy Fact: Up 10.2% YTD ✔ $VXTX ✅ 💰 Ken Griffin/ Citadel have a 93M stake saying otherwise. https://finance.yahoo.com/news/billionaire-ken-griffin-invested-93-092100240.html https://finance.yahoo.com/news/billionaire-ken-griffin-invested-93-092100240.html"
X Link 2024-11-25T11:30Z [---] followers, [---] engagements
"$VKTX $NVO $HIMS Feb [--] (Reuters) - Hims & Hers said in a statement on Saturday that it will stop offering access to the compounded semaglutide pill after the U.S. Food and Drug Administration said it would take action against the telehealth provider for its $49 WT loss pill ✔"
X Link 2026-02-07T20:19Z [---] followers, [---] engagements
"@semodough A. F. has been a basher for years regarding $VKTX Its curious whether or not financial incentives have been given to him or not I use to debate with him on the merits of Viking - but he insulates himself & then blocks any posters that have compelling points on the Company. ✔"
X Link 2026-02-12T22:57Z [---] followers, [---] engagements
"@wallstlobo @semodough [--] phase [--] Trials will be moving along in [----] for the only GLP/GIP Co-Agonist in SQ & Oral form using the same molecule. 25M shorts w/ many being MMs are using it to scalp. Just wait till it gets close to FDA approval & commercialization (- $85 will look cheap) $VKTX"
X Link 2026-02-14T08:07Z [---] followers, [---] engagements
"$VKTX ✅ Obesity ✔ Now desperate $VKTX longs getting some doctor to say that obesity isnt a choice. Its a result of mental weakness and poor decisions. There should be no sympathy for fat people. Now desperate $VKTX longs getting some doctor to say that obesity isnt a choice. Its a result of mental weakness and poor decisions. There should be no sympathy for fat people"
X Link 2024-12-02T03:54Z [---] followers, [---] engagements
"$NVO $VKTX @maziardoustdar Quite succinct & compelling ✅ I am sorry $NVO @maziardoustdar . U r doing a good job but still not your scientists. U talk to Bloomberg ( below ) about big desire for M&A and describe that no one is better than Novo in valuing potential targets. But $PFE @AlbertBourla saved u from Metsera deal that I am sorry $NVO @maziardoustdar . U r doing a good job but still not your scientists. U talk to Bloomberg ( below ) about big desire for M&A and describe that no one is better than Novo in valuing potential targets. But $PFE @AlbertBourla saved u from Metsera deal that"
X Link 2026-02-12T11:29Z [---] followers, [---] engagements
"I am sorry $NVO @maziardoustdar . U r doing a good job but still not your scientists. U talk to Bloomberg ( below ) about big desire for M&A and describe that no one is better than Novo in valuing potential targets. But $PFE @AlbertBourla saved u from Metsera deal that could have ended Novo position in top [--] obesity players by [----] Several other obesity hopefuls got their hands on GLP1 GIP dual agonists ( $RHHBY $REGN most recently $AZN ) $VKTX still has the best one by far the most advanced and moving oral to phase [--] . It will get it combined with oral amylin later this year. This could"
X Link 2026-02-12T10:33Z [----] followers, [----] engagements
"$VKTX $NVO $HIMS Feb [--] (Reuters) - Hims & Hers said in a statement on Saturday that it will stop offering access to the compounded semaglutide pill after the U.S. Food and Drug Administration said it would take action against the telehealth provider for its $49 WT loss pill ✔"
X Link 2026-02-07T20:19Z [---] followers, [---] engagements
"$VKTX ✅ $VKTX Stifel VK2735 boasts one of most flexible profiles in incretin landscape: most unique element of VK2735's development program is flexibility to transition patients from high doses to low maintenance doses. In Ph.2 VENTURE-Injectable 94% of all VK2735 (2.5 mg [--] mg [--] mg https://t.co/2bynNMMTt5 $VKTX Stifel VK2735 boasts one of most flexible profiles in incretin landscape: most unique element of VK2735's development program is flexibility to transition patients from high doses to low maintenance doses. In Ph.2 VENTURE-Injectable 94% of all VK2735 (2.5 mg [--] mg [--] mg"
X Link 2025-10-10T12:45Z [---] followers, [---] engagements
"$VKTX Stifel VK2735 boasts one of most flexible profiles in incretin landscape: most unique element of VK2735's development program is flexibility to transition patients from high doses to low maintenance doses. In Ph.2 VENTURE-Injectable 94% of all VK2735 (2.5 mg [--] mg [--] mg and [--] mg) patients in the PK subset (N=63) maintained weight loss and 83% maintained weight loss out to [--] weeks post-treatment. In VENTURE-Oral an exploratory step-down maintenance cohort (rapidly up-titrated up to [--] mg over [--] weeks and dropped to [--] mg for the remaining [--] weeks) further extended weight loss"
X Link 2025-10-10T10:50Z 42.5K followers, 25.6K engagements
"$VKTX ✅ $VKTX- Near term catalysts: Should start Ph2 Maintenance study in Obesity for #VK2735 this month that includes monthly subq and low dose oral options. (this one could happen any day now.) Should have IND and ph1 study in Amylin/Dacra Compound by EOY Vanquish PH3 subq https://t.co/6mSKykUz3p $VKTX- Near term catalysts: Should start Ph2 Maintenance study in Obesity for #VK2735 this month that includes monthly subq and low dose oral options. (this one could happen any day now.) Should have IND and ph1 study in Amylin/Dacra Compound by EOY Vanquish PH3 subq https://t.co/6mSKykUz3p"
X Link 2025-10-10T12:44Z [---] followers, [---] engagements
"$VKTX- Near term catalysts: Should start Ph2 Maintenance study in Obesity for #VK2735 this month that includes monthly subq and low dose oral options. (this one could happen any day now.) Should have IND and ph1 study in Amylin/Dacra Compound by EOY Vanquish PH3 subq study initiated Jun 25th. Enrollment going well and next up is announcement of completion full enrollment. Other events that could drive the stock higher: - Renewed interest in MASH drugs due to MDGL success (and FDA relaxing Biopsy reqs for ph3) could lead to partnership of #VK2809 - Interest rates continue to decline and lead"
X Link 2025-10-10T11:22Z [----] followers, 34.4K engagements
"$VKTX ✔ 💊 Stanley Druckenmiller just bought into Viking Therapeutics $VKTX. The stock is down 35% YTD. Why would a billionaire hedge fund legend double down here [--] $VKTX is chasing the $120 billion obesity drug market [--] Its pipeline shows early promise vs. Eli Lilly & Novo Nordisk 💊 Stanley Druckenmiller just bought into Viking Therapeutics $VKTX. The stock is down 35% YTD. Why would a billionaire hedge fund legend double down here [--] $VKTX is chasing the $120 billion obesity drug market [--] Its pipeline shows early promise vs. Eli Lilly & Novo Nordisk"
X Link 2025-08-27T15:29Z [---] followers, [---] engagements
"💊 Stanley Druckenmiller just bought into Viking Therapeutics $VKTX. The stock is down 35% YTD. Why would a billionaire hedge fund legend double down here [--] $VKTX is chasing the $120 billion obesity drug market [--] Its pipeline shows early promise vs. Eli Lilly & Novo Nordisk $LLY $NVO [--] Druckenmiller already owns $LLY $VKTX could be his hedge or his multibagger bet This is asymmetric investing 101: small downside massive upside if even one drug hits. Is $VKTX the next big biotech breakout or another what could have been I break it down in my full analysis (free for followers). Follow"
X Link 2025-08-27T15:00Z [----] followers, [----] engagements
"$VKTX ✔ $VKTX 30mg VK2735 was as tolerable as PLACEBO and after [--] weeks SAEs dropped dramatically. Guess what VKTX does in ph2b or ph3 They put patients on 30mg or less for a month and then titrate up as eventual terminal WL is IDENTICAL just takes about a month longer https://t.co/rAfpq9h1V7 $VKTX 30mg VK2735 was as tolerable as PLACEBO and after [--] weeks SAEs dropped dramatically. Guess what VKTX does in ph2b or ph3 They put patients on 30mg or less for a month and then titrate up as eventual terminal WL is IDENTICAL just takes about a month longer https://t.co/rAfpq9h1V7"
X Link 2025-08-27T15:20Z [---] followers, [---] engagements
"$VKTX 30mg VK2735 was as tolerable as PLACEBO and after [--] weeks SAEs dropped dramatically. Guess what VKTX does in ph2b or ph3 They put patients on 30mg or less for a month and then titrate up as eventual terminal WL is IDENTICAL just takes about a month longer"
X Link 2025-08-25T22:57Z [---] followers, [----] engagements
"$VKTX ✔ $vktx $lly Cross-trial comparisons with orforglipron show how competitive VK2735 results are at the [--] mg (maintenance dose) and [--] mg levels. VK2735 reached in [--] weeks what orfo required [--] weeks to achieve in P2 (with a faster titration) and even [--] weeks in P3 (with https://t.co/5ASnhWoH8D $vktx $lly Cross-trial comparisons with orforglipron show how competitive VK2735 results are at the [--] mg (maintenance dose) and [--] mg levels. VK2735 reached in [--] weeks what orfo required [--] weeks to achieve in P2 (with a faster titration) and even [--] weeks in P3 (with https://t.co/5ASnhWoH8D"
X Link 2025-08-25T21:21Z [---] followers, [---] engagements
"$vktx $lly Cross-trial comparisons with orforglipron show how competitive VK2735 results are at the [--] mg (maintenance dose) and [--] mg levels. VK2735 reached in [--] weeks what orfo required [--] weeks to achieve in P2 (with a faster titration) and even [--] weeks in P3 (with optimized titration so it will not get any better than this) all while demonstrating a more favorable safety profile across adverse events. Moreover oral VK may deliver an even stronger efficacy and safety profile once optimized titration schedules are applied (more on titration in a future post). By contrast orfo P3 results"
X Link 2025-08-25T17:23Z [----] followers, 35.8K engagements
"$VKTX ✔ $VKTX Having P2 data for both the oral and SC formulations makes it possible to identify true equivalences between treatment arms based on actual trial outcomes. When plotting WL against each GI adverse event several important insights emerge ones that (at least to my https://t.co/Hls31Plvra $VKTX Having P2 data for both the oral and SC formulations makes it possible to identify true equivalences between treatment arms based on actual trial outcomes. When plotting WL against each GI adverse event several important insights emerge ones that (at least to my https://t.co/Hls31Plvra"
X Link 2025-08-23T18:27Z [---] followers, [---] engagements
"$VKTX Having P2 data for both the oral and SC formulations makes it possible to identify true equivalences between treatment arms based on actual trial outcomes. When plotting WL against each GI adverse event several important insights emerge ones that (at least to my knowledge the market has completely overlooked) as I havent seen anyone comment on them yet: [--]. After adjusting for placebo it becomes clear that the real equivalences are between: oral [--] mg and SC [---] mg oral [--] mg and SC [--] mg oral [---] mg and SC [--] mg The similarity in both efficacy and safety across these matched arms is"
X Link 2025-08-23T08:59Z [----] followers, 42.3K engagements
"$VKTX ✅ @MeadowCapital @MeadowCapital- I have many thoughts on the $VKTX agreement with Corden. Mainly it is exceptionally positive for Viking. This deal gives VKTX multi metric ton/multi billion $ sales potential at "typical pharma margins" for what amounts to a zero dollar capital investment given @MeadowCapital @MeadowCapital- I have many thoughts on the $VKTX agreement with Corden. Mainly it is exceptionally positive for Viking. This deal gives VKTX multi metric ton/multi billion $ sales potential at "typical pharma margins" for what amounts to a zero dollar capital investment given"
X Link 2025-03-14T02:15Z [---] followers, [---] engagements
"@MeadowCapital- I have many thoughts on the $VKTX agreement with Corden. Mainly it is exceptionally positive for Viking. This deal gives VKTX multi metric ton/multi billion $ sales potential at "typical pharma margins" for what amounts to a zero dollar capital investment given the $150 mill will be applied to product purchase. Unreal. Kudos to Brian Lian (and Greg Zante) for making this happen. I didn't think Corden was a potential partner because I thought LLY would have locked them into a non-compete before contracting them to make TRZ. Well clearly that was not the case. I'm guessing"
X Link 2025-03-13T11:38Z [----] followers, [----] engagements
"$VKTX ✅ The value proposition of Viking is being put on the map again with Phase [--] Oral & Phase [--] SQ ready - assets if this partnership is worth 5.3B ✔ $lly $VKTX $NVO $RHHBY tell me you're drug not achieving good WL without telling me https://t.co/5yefi3af6o $lly $VKTX $NVO $RHHBY tell me you're drug not achieving good WL without telling me https://t.co/5yefi3af6o"
X Link 2025-03-12T10:40Z [---] followers, [---] engagements
"$lly $VKTX $NVO $RHHBY tell me you're drug not achieving good WL without telling me https://endpts.com/roches-cardiometabolic-chief-warns-against-weight-loss-obsession-with-glp-1s/ https://endpts.com/roches-cardiometabolic-chief-warns-against-weight-loss-obsession-with-glp-1s/"
X Link 2025-01-17T14:04Z [----] followers, 10.1K engagements
"$VKTX Absolutely back the strategy of B.L. & the BOD to set the floor- reduce the float- and make shorts try and play the longer game w/ Phase [--] oral data coming circa August. Punchbowl 🍷 has been taken from the shorts ✅ BTW: Like whom they hired to run the 250M ✔"
X Link 2025-02-28T20:21Z [---] followers, [----] engagements
"$VKTX ✅ Buckle up - this is going to be very interesting regarding strategy and timing from the Brass at Viking ✔ Really like the move by CEO & BOD ✔ $VKTX buy back and what it could mean BTW I had a feeling the delayed 10K was going to be meaningful novice investors and bears didn't get it. A Pre-commercial biotech company buying back stock is very rare. Someone called $VKTX a scam yesterday if that's the case than $VKTX buy back and what it could mean BTW I had a feeling the delayed 10K was going to be meaningful novice investors and bears didn't get it. A Pre-commercial biotech company"
X Link 2025-02-27T01:46Z [---] followers, [----] engagements
"$VKTX buy back and what it could mean BTW I had a feeling the delayed 10K was going to be meaningful novice investors and bears didn't get it. A Pre-commercial biotech company buying back stock is very rare. Someone called $VKTX a scam yesterday if that's the case than they'd have to be the dumbest scammers is history. Here are a few things to consider Yes this could simply be a testament of their Cash Reserves but for them to buy stock in a critical phase in their development a phase likely to be the most expensive in their Hx usually requiring cash reserves it makes me wonder if it's a sign"
X Link 2025-02-27T01:28Z [----] followers, 31.7K engagements
"$VKTX ✅ $Abbv $PFE $MRK $NVo $VKTX $GPCR People tend to focus on Pfizer and Merck for obesity M&A obviously all BP likely looking at Lilly and novo success and market size. But one that is unfairly dropped from discussions is Abbvie. They are known to make sudden bold moves and outbid $Abbv $PFE $MRK $NVo $VKTX $GPCR People tend to focus on Pfizer and Merck for obesity M&A obviously all BP likely looking at Lilly and novo success and market size. But one that is unfairly dropped from discussions is Abbvie. They are known to make sudden bold moves and outbid"
X Link 2025-02-26T03:30Z [---] followers, [---] engagements
"$Abbv $PFE $MRK $NVo $VKTX $GPCR People tend to focus on Pfizer and Merck for obesity M&A obviously all BP likely looking at Lilly and novo success and market size. But one that is unfairly dropped from discussions is Abbvie. They are known to make sudden bold moves and outbid all. Often with good follow up success and occasionally failure as happened recently Abbvie. CEO at JPM I think overall we have a very strong M&A track record. That said there's a large market with high unmet need and we see a differentiation that we can drive. We've proven in the past we've entered markets like you"
X Link 2025-02-26T01:33Z [----] followers, 24.1K engagements
"$VKTX $PFE @BenzyStocks There are dozens of clues about Pfizer interest in Viking last few weeks ( I and others summarized ) . It is a fact that doesnt need a rumor. The main issue is the value gap and how they can resolve that. Viking CEO will not sell less than $20 B ( watching this guy for years @BenzyStocks There are dozens of clues about Pfizer interest in Viking last few weeks ( I and others summarized ) . It is a fact that doesnt need a rumor. The main issue is the value gap and how they can resolve that. Viking CEO will not sell less than $20 B ( watching this guy for years"
X Link 2025-02-22T20:42Z [---] followers, [---] engagements
"There are dozens of clues about Pfizer interest in Viking last few weeks ( I and others summarized ) . It is a fact that doesnt need a rumor. The main issue is the value gap and how they can resolve that. Viking CEO will not sell less than $20 B ( watching this guy for years ) . Probably some SP appreciation due to rumors and speculations would help both parties . ( and also some competition on deal by others including NVO that could hurt a lot from such deal )"
X Link 2025-02-22T16:47Z [----] followers, [----] engagements
"$VKTX ✅ Truist $VKTX Joon Lee hosting mgmnt for a virtual NDR on Friday 2/21. Truist $VKTX Joon Lee hosting mgmnt for a virtual NDR on Friday 2/21"
X Link 2025-02-20T11:39Z [---] followers, [---] engagements
"Truist $VKTX Joon Lee hosting mgmnt for a virtual NDR on Friday 2/21"
X Link 2025-02-07T14:47Z 42.5K followers, 23.1K engagements
"$VKTX ✅ $VKTX There is big interest in oral VK2735. Phase [--] centers are not accepting new pts ( multiple sources ). Identified [---] pts in no time. We should hear about enrollment close soon. Suggest to me phase [--] enrollment should be record time likely within weeks rather than $VKTX There is big interest in oral VK2735. Phase [--] centers are not accepting new pts ( multiple sources ). Identified [---] pts in no time. We should hear about enrollment close soon. Suggest to me phase [--] enrollment should be record time likely within weeks rather than"
X Link 2025-02-19T21:54Z [---] followers, [---] engagements
"$VKTX There is big interest in oral VK2735. Phase [--] centers are not accepting new pts ( multiple sources ). Identified [---] pts in no time. We should hear about enrollment close soon. Suggest to me phase [--] enrollment should be record time likely within weeks rather than months"
X Link 2025-02-19T19:28Z [----] followers, [----] engagements
"$VKTX ✅ $VKTX Upcoming Investor Events. Viking management will participate in the following upcoming investor events: Oppenheimer 35th Annual Healthcare Life Sciences Conference Virtual February [--] [--] [----] $VKTX Upcoming Investor Events. Viking management will participate in the following upcoming investor events: Oppenheimer 35th Annual Healthcare Life Sciences Conference Virtual February [--] [--] 2025"
X Link 2025-02-07T22:17Z [---] followers, [---] engagements
"$VKTX Upcoming Investor Events. Viking management will participate in the following upcoming investor events: Oppenheimer 35th Annual Healthcare Life Sciences Conference Virtual February [--] [--] 2025"
X Link 2025-02-07T21:46Z [----] followers, [----] engagements
"$VKTX ✅ $VKTX $PFE $NVO $LLy Viking. Raymond James increased prices target $125. Strong buy https://t.co/7uHV5nJikX $VKTX $PFE $NVO $LLy Viking. Raymond James increased prices target $125. Strong buy https://t.co/7uHV5nJikX"
X Link 2025-02-06T12:45Z [---] followers, [---] engagements
"$VKTX $PFE $NVO $LLy Viking. Raymond James increased prices target $125. Strong buy"
X Link 2025-02-06T12:42Z [----] followers, 32K engagements
"$VKTX ✅ $vktx $LLY $NVO $pFe Oppenheimer Viking. EC preview .manufacturing agreement that will support multi billion commercial opportunity. No issue in phase [--] https://t.co/FYbmdPLD97 $vktx $LLY $NVO $pFe Oppenheimer Viking. EC preview .manufacturing agreement that will support multi billion commercial opportunity. No issue in phase [--] https://t.co/FYbmdPLD97"
X Link 2025-02-04T22:22Z [---] followers, [---] engagements
"$vktx $LLY $NVO $pFe Oppenheimer Viking. EC preview .manufacturing agreement that will support multi billion commercial opportunity. No issue in phase 3"
X Link 2025-02-04T12:35Z [----] followers, 21.6K engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/creator/twitter::willjohn1517